<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Physiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id><journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id><journal-title-group><journal-title>Frontiers in Physiology</journal-title></journal-title-group><issn pub-type="epub">1664-042X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31001130</article-id><article-id pub-id-type="pmc">6454349</article-id><article-id pub-id-type="doi">10.3389/fphys.2019.00324</article-id><article-categories><subj-group subj-group-type="heading"><subject>Physiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>CXCR2 Blockade Mitigates Neural Cell Injury Following Preclinical Chorioamnionitis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yellowhair</surname><given-names>Tracylyn R.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/659293/overview"/></contrib><contrib contrib-type="author"><name><surname>Newville</surname><given-names>Jessie C.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/431404/overview"/></contrib><contrib contrib-type="author"><name><surname>Noor</surname><given-names>Shahani</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/436879/overview"/></contrib><contrib contrib-type="author"><name><surname>Maxwell</surname><given-names>Jessie R.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/431135/overview"/></contrib><contrib contrib-type="author"><name><surname>Milligan</surname><given-names>Erin D.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/142930/overview"/></contrib><contrib contrib-type="author"><name><surname>Robinson</surname><given-names>Shenandoah</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/543905/overview"/></contrib><contrib contrib-type="author"><name><surname>Jantzie</surname><given-names>Lauren L.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/247147/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Pediatrics, School of Medicine, The University of New Mexico</institution>, <addr-line>Albuquerque, NM</addr-line>, <country>United States</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Neurosciences, School of Medicine, The University of New Mexico</institution>, <addr-line>Albuquerque, NM</addr-line>, <country>United States</country></aff><aff id="aff3"><sup>3</sup><institution>Division of Pediatric Neurosurgery, Department of Neurosurgery, The Johns Hopkins University School of Medicine</institution>, <addr-line>Baltimore, MD</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Justin Dean, The University of Auckland, New Zealand</p></fn><fn fn-type="edited-by"><p>Reviewed by: Courtney Anne McDonald, Hudson Institute of Medical Research, Australia; Madison Claire Badawy Paton, Cerebral Palsy Alliance Research Institute, Australia</p></fn><corresp id="c001">*Correspondence: Lauren L. Jantzie, <email>LJantzie@jhmi.edu</email></corresp><fn fn-type="other" id="fn002"><p><sup>&#x02020;</sup>Present address: Lauren L. Jantzie, Division of Neonatology, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD, United States</p></fn><fn fn-type="other" id="fn003"><p>This article was submitted to Embryonic and Developmental Physiology, a section of the journal Frontiers in Physiology</p></fn></author-notes><pub-date pub-type="epub"><day>02</day><month>4</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>10</volume><elocation-id>324</elocation-id><history><date date-type="received"><day>15</day><month>11</month><year>2018</year></date><date date-type="accepted"><day>11</day><month>3</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Yellowhair, Newville, Noor, Maxwell, Milligan, Robinson and Jantzie.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Yellowhair, Newville, Noor, Maxwell, Milligan, Robinson and Jantzie</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Minimizing central nervous system (CNS) injury from preterm birth depends upon identification of the critical pathways that underlie essential neurodevelopmental and CNS pathophysiology. While chorioamnionitis (CHORIO), is a leading cause of preterm birth, the precise mechanism linking prenatal brain injury and long-term CNS injury is unknown. The chemokine (C-X-C motif) ligand 1 (CXCL1) and its cognate receptor, CXCR2, are implicated in a variety of uterine and neuropathologies, however, their role in CNS injury associated with preterm birth is poorly defined. To evaluate the putative efficacy of CXCR2 blockade in neural repair secondary to CHORIO, we tested the hypothesis that transient postnatal CXCR2 antagonism would reduce neutrophil activation and mitigate cerebral microstructural injury in rats. To this end, a laparotomy was performed on embryonic day 18 (E18) in Sprague Dawley rats, with uterine arteries transiently occluded for 60 min, and lipopolysaccharide (LPS, 4 &#x003bc;g/sac) injected into each amniotic sac. SB225002, a CXCR2 antagonist (3 mg/kg), was administered intraperitoneally from postnatal day 1 (P1)-P5. Brains were collected on P7 and P21 and analyzed with western blot, immunohistochemistry and <italic>ex vivo</italic> diffusion tensor imaging (DTI). Results demonstrate that transient CXCR2 blockade reduced cerebral neutrophil activation (myeloperoxidase expression/MPO) and mitigated connexin43 expression, indicative of reduced neuroinflammation at P7 (<italic>p</italic> &#x0003c; 0.05 for all). CXCR2 blockade also reduced alpha II-spectrin calpain-mediated cleavage, improved pNF/NF ratio, and minimized Iba1 and GFAP expression consistent with improved neuronal and axonal health and reduced gliosis at P21. Importantly, DTI revealed diffuse white matter injury and decreased microstructural integrity following CHORIO as indicated by lower fractional anisotropy (FA) and elevated radial diffusivity (RD) in major white matter tracts (<italic>p</italic> &#x0003c; 0.05). Early postnatal CXCR2 blockade also reduced microstructural abnormalities in white matter and hippocampus at P21 (<italic>p</italic> &#x0003c; 0.05). Together, these data indicate that transient postnatal blockade of CXCR2 ameliorates perinatal abnormalities in inflammatory signaling, and facilitates neural repair following CHORIO. Further characterization of neuroinflammatory signaling, specifically via CXCL1/CXCR2 through the placental-fetal-brain axis, may clarify stratification of brain injury following preterm birth, and improve use of targeted interventions in this highly vulnerable patient population.</p></abstract><kwd-group><kwd>preterm</kwd><kwd>chemokine</kwd><kwd>CXCL1</kwd><kwd>diffusion tensor imaging</kwd><kwd>neutrophil</kwd><kwd>white matter</kwd><kwd>alpha-II spectrin</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source><award-id rid="cn001">1R01HL139492</award-id><award-id rid="cn001">1S10OD021598</award-id></award-group></funding-group><counts><fig-count count="6"/><table-count count="1"/><equation-count count="0"/><ref-count count="91"/><page-count count="11"/><word-count count="0"/></counts></article-meta></front><body><sec><title>Introduction</title><p>Perinatal brain injury (PBI) is a major contributor to long-term disability in children across the globe (<xref rid="B8" ref-type="bibr">Blencowe et al., 2012</xref>, <xref rid="B9" ref-type="bibr">2013</xref>; <xref rid="B48" ref-type="bibr">Kochanek et al., 2012</xref>). For a large proportion of infants with PBI, central nervous system (CNS) injury begins <italic>in utero</italic> secondary to inflammation (chorioamnionitis/CHORIO) and/or hypoxia-ischemia (HI) with placental insufficiency (<xref rid="B21" ref-type="bibr">Dammann and Leviton, 1997</xref>, <xref rid="B22" ref-type="bibr">2014</xref>; <xref rid="B28" ref-type="bibr">Goldenberg et al., 2000</xref>; <xref rid="B49" ref-type="bibr">Lee J. et al., 2013</xref>; <xref rid="B50" ref-type="bibr">Lee S.M. et al., 2013</xref>; <xref rid="B15" ref-type="bibr">Chau et al., 2014</xref>; <xref rid="B24" ref-type="bibr">Fant et al., 2014</xref>). Specifically defined as infection/inflammation of the amniotic fluid, membranes, and placenta, concomitant with neutrophil infiltration into the choriodecidua along a chemotactic gradient of pro-inflammatory chemokines, (<xref rid="B88" ref-type="bibr">Yanowitz et al., 2002</xref>; <xref rid="B49" ref-type="bibr">Lee J. et al., 2013</xref>; <xref rid="B50" ref-type="bibr">Lee S.M. et al., 2013</xref>; <xref rid="B44" ref-type="bibr">Kallapur et al., 2014</xref>; <xref rid="B47" ref-type="bibr">Kim et al., 2015</xref>) CHORIO creates a toxic <italic>in utero</italic> microenvironment that limits oxygen exchange and propagates inflammation during critical periods of neurodevelopment (<xref rid="B64" ref-type="bibr">Redline, 2009</xref>, <xref rid="B65" ref-type="bibr">2013</xref>; <xref rid="B26" ref-type="bibr">Galinsky et al., 2013</xref>; <xref rid="B3" ref-type="bibr">Anblagan et al., 2016</xref>). Typically, infants with PBI present with injury to major white and gray matter structures, leading to reduced connectivity of developing networks. Subsequently, diverse functional deficits ensue with impairment in multiple motor, cognitive and emotional realms, including educational under underachievement in childhood (<xref rid="B20" ref-type="bibr">Counsell et al., 2008</xref>; <xref rid="B10" ref-type="bibr">Boardman et al., 2010</xref>).</p><p>While CHORIO is implicated in preterm CNS injury, the molecular mechanisms meadiating inflammation in the placental-fetal-brain axis that causes PBI remains a gap in knowledge. Specifically, the overlap between placental and CNS physiology and the bi-directional cross talk between the developing immune system and neurodevelopment is relatively unknown. In pregnancy, the physiologic roles for chemokines are well described and dysregulated cytokine production due to infection has tremendous impact on the developing fetus (<xref rid="B30" ref-type="bibr">Hagberg and Mallard, 2005</xref>; <xref rid="B4" ref-type="bibr">Bastek et al., 2011</xref>; <xref rid="B31" ref-type="bibr">Hagberg et al., 2015</xref>). Notably, the chemokine (C-X-C motif) ligand 1 (CXCL1) and its cognate receptor (CXCR2) have been clinically implicated in the pathophysiology of CHORIO (<xref rid="B33" ref-type="bibr">Hsu et al., 1998</xref>; <xref rid="B54" ref-type="bibr">Lockwood et al., 2006</xref>; <xref rid="B6" ref-type="bibr">Bergeron et al., 2016</xref>). CXCL1 provides a chemotactic gradient for neutrophil infiltration to the maternal-fetal interface, and is extensively upregulated with intrauterine inflammation (<xref rid="B33" ref-type="bibr">Hsu et al., 1998</xref>; <xref rid="B54" ref-type="bibr">Lockwood et al., 2006</xref>). CXCL1 is also a major player in pregnancy failure from CHORIO (<xref rid="B74" ref-type="bibr">Saini et al., 2011</xref>; <xref rid="B58" ref-type="bibr">Mizugishi et al., 2015</xref>). Indeed, the severity of pathologic placental inflammation correlates positively with CXCL1 levels in newborns with CHORIO and funisitis, (<xref rid="B11" ref-type="bibr">Bry et al., 2015</xref>) and CXCL1 is upregulated in amniotic fluid, umbilical cord, and maternal plasma in both term and preterm babies with amniotic infection (<xref rid="B18" ref-type="bibr">Cohen et al., 1996</xref>). Pregnant women with intra-amniotic infection have significantly higher amniotic fluid concentrations of CXCL1, (<xref rid="B33" ref-type="bibr">Hsu et al., 1998</xref>) and high CXCL1 levels correlate with maternal and newborn peripheral white blood cell counts (<xref rid="B18" ref-type="bibr">Cohen et al., 1996</xref>).</p><p>In the brain, chemokine receptors play a crucial role in the onset, regulation, and propagation of inflammation. They are also essential in cellular communication, neuronal survival, and neural transmission (<xref rid="B63" ref-type="bibr">Reaux-Le Goazigo et al., 2013</xref>; <xref rid="B86" ref-type="bibr">Xu et al., 2017</xref>). CXCR2 is one of the most well characterized chemokine receptors, and is located at the cell surface and in the cytoplasm (<xref rid="B78" ref-type="bibr">Semple et al., 2010b</xref>; <xref rid="B82" ref-type="bibr">Veenstra and Ransohoff, 2012</xref>; <xref rid="B12" ref-type="bibr">Cao et al., 2014</xref>; <xref rid="B86" ref-type="bibr">Xu et al., 2017</xref>). CXCL1 is the dominant CXCR2 ligand expressed in the inflamed CNS, and its levels are directly proportional to its function (<xref rid="B46" ref-type="bibr">Kielian et al., 2001</xref>; <xref rid="B14" ref-type="bibr">Carlson et al., 2008</xref>; <xref rid="B45" ref-type="bibr">Kerstetter et al., 2009</xref>; <xref rid="B53" ref-type="bibr">Liu et al., 2010</xref>; <xref rid="B72" ref-type="bibr">Roy et al., 2012</xref>; <xref rid="B82" ref-type="bibr">Veenstra and Ransohoff, 2012</xref>). Signaling through CXCR2 is a non-redundant driving force for neutrophil recruitment from blood (<xref rid="B77" ref-type="bibr">Semple et al., 2010a</xref>). CXCR2 is also expressed on oligodendrocyte progenitors (OPCs) and microglia in the fetal brains as early as 19&#x02013;22 weeks gestation (<xref rid="B25" ref-type="bibr">Filipovic et al., 2003</xref>), and CXCR2 activation by CXCL1 on OPCs regulates their proliferation and migration (<xref rid="B69" ref-type="bibr">Robinson et al., 1998</xref>; <xref rid="B68" ref-type="bibr">Robinson and Franic, 2001</xref>). Additionally, CXCR2 is constitutively expressed on other neural cells including neurons, astrocytes, (<xref rid="B25" ref-type="bibr">Filipovic et al., 2003</xref>) and monocytes (<xref rid="B81" ref-type="bibr">Valles et al., 2006</xref>; <xref rid="B51" ref-type="bibr">Lindner et al., 2008</xref>; <xref rid="B82" ref-type="bibr">Veenstra and Ransohoff, 2012</xref>). Multiple reports have suggested a role for aberrant CXCL1/CXCR2 signaling in adult CNS injury including stroke, traumatic brain injury (TBI), temporal lobe epilepsy, (<xref rid="B86" ref-type="bibr">Xu et al., 2017</xref>) neuropathic nociception, (<xref rid="B1" ref-type="bibr">Abbadie et al., 2009</xref>; <xref rid="B87" ref-type="bibr">Yang et al., 2016</xref>) central sensitization, (<xref rid="B91" ref-type="bibr">Zhang et al., 2013</xref>; <xref rid="B56" ref-type="bibr">Manjavachi et al., 2014</xref>) and mechanical hypersensitivity (<xref rid="B16" ref-type="bibr">Chen et al., 2018</xref>). Despite the wealth of scientific knowledge of CXCL1/CXCR2 pathophysiology in the mature CNS, their specific role in the pathophysiology in PBI is undefined.</p><p>Previously, we published that upregulation of CXCL1 commencing <italic>in utero</italic> negatively affects the fetal microenvironment and trajectory of CNS development (<xref rid="B34" ref-type="bibr">Jantzie et al., 2014a</xref>, <xref rid="B40" ref-type="bibr">2018</xref>; <xref rid="B57" ref-type="bibr">Maxwell et al., 2015</xref>; <xref rid="B89" ref-type="bibr">Yellowhair et al., 2018</xref>). Specifically, CXCL1/CXCR2 signaling is increased following CHORIO in rat placenta, fetal and neonatal circulation and brain over an extended developmental time course, concomitant with increased numbers of placental and cerebral CXCR2-positive neutrophils, and other markers of neuroinflammation (<xref rid="B89" ref-type="bibr">Yellowhair et al., 2018</xref>). Thus, to evaluate the putative efficacy of CXCR2 blockade in neural repair following CHORIO, we tested the hypothesis that transient postnatal CXCR2 antagonism would reduce neutrophil activation, mitigate inflammation and neural injury, and preserve brain diffusion and microstructure following CHORIO in rats. The goal of this investigation was to connect aberrant CXCL1/CXCR2 signaling to PBI secondary to CHORIO, and putatively define novel targets for directed therapies for infants at high risk for PBI from CHORIO and related etiologies.</p></sec><sec sec-type="materials|methods" id="s1"><title>Materials and Methods</title><sec><title>Animals</title><p>All procedures were performed consistent with National Research Council guidelines, and with the approval of the Institutional Animal Care and Use Committee (IACUC) at the University of New Mexico Health Sciences Center. ARRIVE guidelines were followed.</p></sec><sec><title>In Utero Chorioamnionitis (CHORIO)</title><p>We used an established model of CHORIO that yields deficits in the mature CNS that mimic those of preterm survivors (<xref rid="B34" ref-type="bibr">Jantzie et al., 2014a</xref>, <xref rid="B40" ref-type="bibr">2018</xref>; <xref rid="B57" ref-type="bibr">Maxwell et al., 2015</xref>; <xref rid="B89" ref-type="bibr">Yellowhair et al., 2018</xref>). Specifically, pregnant Sprague Dawley rats underwent abdominal laparotomy on embryonic day 18 (E18), consistent with previous reports (<xref rid="B39" ref-type="bibr">Jantzie et al., 2013</xref>, <xref rid="B34" ref-type="bibr">2014a</xref>,<xref rid="B38" ref-type="bibr">b</xref>, <xref rid="B35" ref-type="bibr">2015a</xref>,<xref rid="B36" ref-type="bibr">b</xref>, <xref rid="B40" ref-type="bibr">2018</xref>; <xref rid="B57" ref-type="bibr">Maxwell et al., 2015</xref>; <xref rid="B89" ref-type="bibr">Yellowhair et al., 2018</xref>). Uterine arteries were transiently occluded for 60 min, to induce placental insufficiency, followed by an intra-amniotic injection of lipopolysaccharide (LPS 0111:B4, 4 &#x003bc;g/sac; Sigma-Aldrich, St. Louis, MO, United States). Laparotomies were closed, and the rat pups were born at term on embryonic day 22 (E22). Sham dams underwent anesthesia for an equivalent duration of time without further intervention. Pups were then euthanized on postnatal day (P) 7 or P21 for biochemical or <italic>ex vivo</italic> magnetic resonance imaging (MRI) analyses. Previously, we reported the placental pathology, Fetal Inflammatory Response Syndrome (FIRS), neuroinflammatory responses, as well as MRI outcomes and the long-term cognitive and motor functional abnormalities in this model (<xref rid="B34" ref-type="bibr">Jantzie et al., 2014a</xref>, <xref rid="B40" ref-type="bibr">2018</xref>; <xref rid="B57" ref-type="bibr">Maxwell et al., 2015</xref>; <xref rid="B89" ref-type="bibr">Yellowhair et al., 2018</xref>). For each experiment described, equal numbers of male and female pups were used in each assay, and data represents true n (individual pups) from at least four different dams per condition. A summary diagram of our experimental method is provided as <xref ref-type="fig" rid="F1">Figure 1</xref>.</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Experimental Design. On embryonic day 18 (E18), a prenatal chorioamnionitis insult was induced in pregnant Sprague Dawley rats. Rat pups were born on E22. SB225002, a CXCR2 antagonist, or vehicle, was administered during a critical neonatal window from postnatal day 1 (P1) through P5 (3 mg/kg i.p.). Pup brains were collected and analyzed on P7 or P21 for western blot analysis (WB), <italic>ex vivo</italic> diffusion tensor imaging (DTI), and immunohistochemistry (IHC).</p></caption><graphic xlink:href="fphys-10-00324-g001"/></fig></sec><sec><title>Neonatal Administration of SB225002, a CXCR2 Antagonist</title><p>The selective, competitive CXCR2 antagonist SB225002 (Cayman Chemical, Ann Arbor, MI, United States) was used to block CXCR2 in rats following CHORIO. Previously, SB225002 has been reported to be safe in the developing CNS and has been widely used in adult models of CNS injury (<xref rid="B12" ref-type="bibr">Cao et al., 2014</xref>; <xref rid="B83" ref-type="bibr">Wang et al., 2016</xref>; <xref rid="B86" ref-type="bibr">Xu et al., 2017</xref>). Accordingly, CHORIO rat pups of both sexes were randomly assigned to treatment with SB225002 3 mg/kg (<xref rid="B12" ref-type="bibr">Cao et al., 2014</xref>; <xref rid="B83" ref-type="bibr">Wang et al., 2016</xref>; <xref rid="B86" ref-type="bibr">Xu et al., 2017</xref>) intraperitoneally (i.p.) from P1&#x02013;P5, consistent with prior reports of translatable neonatal neurorepair dosing intervals with other compounds such as erythropoietin and melatonin (<xref ref-type="fig" rid="F1">Figure 1</xref>; <xref rid="B39" ref-type="bibr">Jantzie et al., 2013</xref>, <xref rid="B38" ref-type="bibr">2014b</xref>, <xref rid="B35" ref-type="bibr">2015a</xref>,<xref rid="B36" ref-type="bibr">b</xref>, <xref rid="B40" ref-type="bibr">2018</xref>) SB225002 was prepared by dissolving 25 mg of crystalline solid in 1 mL of DMSO. It was then aliquoted and stored at &#x02212;20&#x000b0;C. On the day of experimentation, frozen SB225002 stock was further diluted to a working concentration of 0.5 mg/mL in 30% DMSO and 70% normal saline, after which a 3 mg/kg dose was prepared for each pup using normal saline. The total injection volume for each injection was 100 &#x003bc;l. Sham rat pups received a vehicle injection of 30% DMSO and 70% normal saline solution only.</p></sec><sec><title>Western Blot</title><p>Microdissected cortical samples from sham, CHORIO, or CHORIO rats treated with CXCR2 antagonist at P7 or P21 were homogenized and sonicated, and centrifuged at 4200 &#x000d7; <italic>g</italic> for 10 min consistent with prior reports (<xref rid="B35" ref-type="bibr">Jantzie et al., 2015a</xref>,<xref rid="B36" ref-type="bibr">b</xref>,<xref rid="B37" ref-type="bibr">c</xref>, <xref rid="B42" ref-type="bibr">2016</xref>). Protein concentration in the whole cell fraction was determined with a Bradford assay (Bio-Rad, Hercules, CA, United States). Thirty micrograms of protein were loaded on 4&#x02013;20% Tris&#x02013;HCl gels or 4&#x02013;12% bis-tris HCl gels (Bio-Rad), separated by electrophoresis, and transferred to polyvinylidene fluoride (PVDF) membranes. Membranes were blocked with 5% non-fat dry milk in TBST and incubated with primary antibody overnight at 4 degrees. A species appropriate horseradish-peroxidase-conjugated secondary antibody (Thermo, Grand Island, NY, United States) was applied, and after washing, detected with chemiluminescence (Thermo) using a LAS 4000 imager (GE, Healthcare, PA). Primary antibodies against the following targets were used consistent with prior publications: alpha-II spectrin (Santa Cruz, Dallas, TX, 1:100), myeloperoxidase (MPO) (AbCam, Cambridge, MA, 1:500, connexin43 (CX43, Cell Signaling, Danvers, MA, 1:500), phosphoneurofilament (pNF, Millipore, Temecula, CA, 1:500) or neurofilament (NF, SMI-312, Covance, Princeton, NJ, 1:1000) (<xref rid="B42" ref-type="bibr">Jantzie et al., 2016</xref>; <xref rid="B89" ref-type="bibr">Yellowhair et al., 2018</xref>). Blots were imaged using an ImageQuant LAS 4000 (GE) and bands of interest were quantified using ImageQuant Software (GE) normalized to the loading control, actin (Sigma, St. Louis, MO, 1:5000). At least two blots were used to assay each protein. Data was then normalized to the sham group consistent with previous reports (<xref rid="B82" ref-type="bibr">Veenstra and Ransohoff, 2012</xref>; <xref rid="B38" ref-type="bibr">Jantzie et al., 2014b</xref>, <xref rid="B35" ref-type="bibr">2015a</xref>, <xref rid="B42" ref-type="bibr">2016</xref>).</p></sec><sec><title>Immunohistochemistry</title><p>On P21 rats were deeply anesthetized with sodium pentobarbital and perfused with 4% paraformaldehyde. Brains were then collected, and post-fixed in paraformaldehyde. After immersion in 30% sucrose solution, 20 &#x003bc;m, frozen, slide mounted, coronal sections were obtained and collected using a cryostat (Leica, Buffalo Grove, IL, United States). Slides were then washed and incubated with 0.3% hydrogen peroxide, followed by blocking solution containing 10% normal goat serum in phosphate buffered solution (PBS). Primary antibodies against glial fibrillary acidic protein (GFAP, Dako 1:500, Carpinteria, CA, United States) or ionized calcium binding adaptor 1 (Iba1, Wako, 1:500, United States), in blocking solution containing 0.1% Trition-X100 were incubated on sections overnight at 4&#x000b0;C. The next day, sections were rinsed, and incubated with species-appropraite biotinylated secondary antibodies for 1 h. This was followed by incubation in VECTASTAIN (Vector Labs, Burlingame, CA, United States) and 3,3&#x02032;-diaminobenzidine (DAB). Sections were then processed for dehydration, cleared in xylenes and cover-slipped in Permount (Millipore Sigma, St. Louis, MO, United States). Appropriate negative controls without primary antibodies were run in parallel. Using bright-field illumination, representative images were photographed on an upright Leica microscope.</p></sec><sec><title>Stereological Estimates</title><p>All P21 sections were coded prior to analyses by a blinded observer and stereology performed consistent with previously published methodology (<xref rid="B34" ref-type="bibr">Jantzie et al., 2014a</xref>, <xref rid="B35" ref-type="bibr">2015a</xref>; <xref rid="B66" ref-type="bibr">Robinson et al., 2017a</xref>). Estimates of the load of each antigen were obtained from 20 &#x003bc;m coronal sections using a thin section modification of the optical fractionator method (<xref rid="B29" ref-type="bibr">Gundersen et al., 1988</xref>; <xref rid="B60" ref-type="bibr">Mouton et al., 2002</xref>). Specifically, object area fraction and volume probes (Cavalieri&#x02019;s method) were used to calculate load and to quantify the amount of Iba1-positive microglia and GFAP-positive astrocytes in the fimbria. At the completion of the stereological analyses, the samples were decoded, and mean and SEM of load were calculated.</p></sec><sec><title>Diffusion Tensor Imaging (DTI)</title><p><italic>Ex vivo</italic> MRI using diffusion sequences was performed on a Bruker BioSpec 7T 70/30 Ultra Shield Refrigerated (USR) nuclear MRI system, consistent with prior published methods (<xref rid="B70" ref-type="bibr">Robinson et al., 2016</xref>, <xref rid="B67" ref-type="bibr">2017b</xref>; <xref rid="B89" ref-type="bibr">Yellowhair et al., 2018</xref>). Briefly, P21 rats were deeply anesthetized with sodium pentobarbital and perfused with 4% paraformaldehyde. Brains were removed from the skull and post-fixed in 4% paraformaldehyde for 1 week and embedded in 2% agarose containing 3 mM sodium azide for immediate <italic>ex vivo</italic> MR imaging. Echo-planar diffusion tensor imaging (EP-DTI) of twenty contiguous coronal 1 mm slices were obtained with a FOV (field-of-view) of 3.00 cm and an MTX of 256. Brain regions of interest (ROI) in major white matter tracts (corpus callosum and external capsule) and gray matter (hippocampus and thalamus), were traced by an observer blinded to experimental conditions and analyzed using Bruker&#x02019;s ParaVision 5.1 imaging software. Fractional anisotropy (FA), axial (&#x003bb;1) and radial [(&#x003bb;2+&#x003bb;3)/2] diffusivity eigenvectors were measured and calculated. For bilateral neuroanatomical ROIs, metrics were acquired on each side and averaged per ROI. Directionally encoded diffusion color maps and color-coded FA maps were created.</p></sec><sec><title>Statistical Analyses</title><p>Data are represented as mean &#x000b1; the standard error of the mean (SEM). Parametric statistical differences between three groups (sham, CHORIO and CHORIO+CXCR2 antagonist) were established using a two-way ANOVA with Bonferroni <italic>post hoc</italic> correction to discern the effects of injury and treatment. <italic>p</italic> &#x0003c; 0.05 was considered statistically significant.</p></sec></sec><sec><title>Results</title><sec><title>Transient Blockade of CXCR2 Attenuates Neutrophil Activation and Reduces Connexin43 Expression</title><p>To first establish putative beneficial effect of CXCR2 blockade on neutrophil activation, a common cellular mediator of inflammation throughout the placental-fetal-brain axis, we examined cerebral myeloperoxidase (MPO) protein expression on P7, 48 h following the last dose of SB225002. As expected, vehicle-treated CHORIO pups had increased MPO expression compared shams (<italic>n</italic> = 10&#x02013;15, <italic>p</italic> &#x0003c; 0.05, <xref ref-type="fig" rid="F2">Figure 2A</xref>). Notably, treatment with SB225002, the CXCR2 antagonist, mitigated neutrophil activation in CHORIO pups and restored MPO protein expression levels to that observed in sham pups (<italic>p</italic> &#x0003c; 0.01, <xref ref-type="fig" rid="F2">Figure 2A</xref>).</p><fig id="F2" position="float"><label>FIGURE 2</label><caption><p>CXCR2 Antagonism Reduces Neutrophil Activation and Connexin43 Expression on Postnatal Day 7 (P7). Following prenatal chorioamnionitis, transient postnatal administration of the CXCR2 antagonist, SB225002, reduced neutrophil reactivity (myeloperoxidase, MPO, <bold>A</bold>) and mitigated connexin43 expression (CX43, <bold>B</bold>) in the cortex on P7, consistent with reduced cellular neuroinflammation. At P7, neither CHORIO or CXCR2 antagonism changed cleaved alpha-II spectrin ratio, a marker of neuronal health <bold>(C)</bold>. (<italic>n</italic> = 7&#x02013;15, two-way ANOVA with Bonferroni&#x02019;s <italic>post hoc</italic> correction, <sup>&#x02217;</sup><italic>p</italic> &#x0003c; 0.05, <sup>&#x02217;&#x02217;</sup><italic>p</italic> &#x0003c; 0.01).</p></caption><graphic xlink:href="fphys-10-00324-g002"/></fig><p>As CXCR2 has been documented to be important in intracellular signaling and communication under normal and inflamed conditions, we also examined the effect of CXCR2 blockade on connexin43 expression, a hemichannel protein that is present in placenta and brain, including on astrocytes and other immune cells (<xref rid="B23" ref-type="bibr">Dunk et al., 2012</xref>; <xref rid="B79" ref-type="bibr">Theodoric et al., 2012</xref>; <xref rid="B17" ref-type="bibr">Chen et al., 2014</xref>; <xref rid="B90" ref-type="bibr">Yin et al., 2018</xref>). Indeed, connexin43 is a gap junction protein intimately connected to CXCR2 activation, astrocyte activation, and excitotoxicity (<xref rid="B79" ref-type="bibr">Theodoric et al., 2012</xref>; <xref rid="B17" ref-type="bibr">Chen et al., 2014</xref>). Consistent with increased neuroinflammatory signal transduction in our model of CHORIO, (<xref rid="B34" ref-type="bibr">Jantzie et al., 2014a</xref>; <xref rid="B89" ref-type="bibr">Yellowhair et al., 2018</xref>) connexin43 protein expression was significantly elevated in the brains of vehicle-treated CHORIO pups at P7 (<italic>n</italic> = 7&#x02013;9, <italic>p</italic> &#x0003c; 0.01, <xref ref-type="fig" rid="F2">Figure 2B</xref>). Similar to the reduction in MPO observed with CXCR2 antagonism, treatment with SB225002 also significantly reduced connexin43 expression at P7 (<italic>p</italic> &#x0003c; 0.05, <xref ref-type="fig" rid="F2">Figure 2B</xref>). We also examined alpha-II spectrin at P7, a neuron specific cytoskeletal protein and target of calpain (<xref rid="B38" ref-type="bibr">Jantzie et al., 2014b</xref>, <xref rid="B42" ref-type="bibr">2016</xref>; <xref rid="B75" ref-type="bibr">Schober et al., 2014</xref>). Consistent with our previous reports, we found no effect of CHORIO or SB225002 administration at P7 on the ratio of full length alpha-II spectrin to cleaved alpha-II spectrin (<italic>n</italic> = 10&#x02013;16 <italic>p</italic> = ns, <xref ref-type="fig" rid="F2">Figure 2C</xref>).</p></sec><sec><title>CXCR2 Antagonism Attenuates CHORIO-Induced Gliosis and Neural Injury</title><p>Given the acute effect of CXCR2 blockade at P7 on neutrophil activation and reduced connexin43 expression, we examined global markers of axons, astrocytes, microglia and assessed neuronal health at P21 to establish longer term effects of CXCR2 blockade (<xref ref-type="fig" rid="F3">Figure 3</xref>). P21 in rats is equivalent to a young, human juvenile and represents a timepoint 4 weeks following <italic>in utero</italic> insult and just over 2 weeks following the last dose of SB225002 (<xref rid="B76" ref-type="bibr">Semple et al., 2013</xref>; <xref rid="B41" ref-type="bibr">Jantzie and Robinson, 2015</xref>). Notably, transient neonatal antagonism of CXCR2 with SB225002 significantly improved the ratio of pNF to NF compared to CHORIO pups treated with vehicle, consistent with improved axonal health in treated pups and similar levels of these key axonal proteins as shams (<italic>n</italic> = 9&#x02013;11, <italic>p</italic> &#x0003c; 0.01, <xref ref-type="fig" rid="F3">Figure 3A</xref>). Given the beneficial effect of CXCR2 antagonism on axons, we then examined the alpha-II spectrin ratio in treated and untreated pups at P21. Importantly, the spectrin ratio in vehicle-treated CHORIO pups was elevated compared to shams (<italic>n</italic> = 6&#x02013;7, <italic>p</italic> &#x0003c; 0.01, <xref ref-type="fig" rid="F3">Figure 3B</xref>), consistent with elevated levels of calpain protease activity and neuronal cytoskeletal breakdown. Notably, treatment with the CXCR2 antagonist SB225002, mitigated the increase in spectrin cleavage ratio and normalized alpha-II spectrin cleavage to sham levels (<italic>n</italic> = 6&#x02013;11, <italic>p</italic> &#x0003c; 0.05, <xref ref-type="fig" rid="F3">Figure 3B</xref>). We also examined microglia and astrocytes at this time point. Immunoreactivity for microglia (Iba1, <xref ref-type="fig" rid="F3">Figure 3C</xref>) and astrocytes (GFAP) (<xref ref-type="fig" rid="F3">Figure 3D</xref>) was augmented at P21 in the fimbria of CHORIO animals compared to Sham, an effect that was ameliorated by CXCR2 antagonism. Using stereological principles, we quantified Iba1 and GFAP load (<xref rid="T1" ref-type="table">Table 1</xref>). These analyses confirmed significant increases in Iba1 and GFAP load induced by CHORIO that was significantly mitaged by CXCR2 antagonism. Together, these data indicated that transient CXCR2 antagonism attenuates gliosis, and reduces axonal and neuronal injury following CHORIO.</p><fig id="F3" position="float"><label>FIGURE 3</label><caption><p>CXCR2 Antagonism Improves Axonal and Neuronal Health Through Postnatal Day 21 (P21). Following prenatal chorioamnionitis (CHORIO), transient postnatal administration of the CXCR2 antagonist, SB225002, mitigated injury-induced alterations in cortical phosphoneurofilament to neurofilament ratio (pNF/NF, <bold>A</bold>), consistent with improved axonal health. Similarly, transient CXCR2 blockade also reduced pathological augmentation of alpha-II spectrin cleavage in the cortex <bold>(B)</bold>, consistent with reduced calpain activity and improved neuronal health. Immunoreactivity for microglia (Iba1, <bold>C</bold>) and astrocytes (GFAP, <bold>D</bold>) is augmented at P21 in CHORIO fimbria compared to Sham, an effect that is ameliorated by CXCR2 antagonism. Scale bar = 200 &#x003bc;m. (<italic>n</italic> = 6&#x02013;11/group for immunoblot, <italic>n</italic> = 3 for immunohistochemistry, two-way ANOVA with Bonferroni&#x02019;s <italic>post hoc</italic> correction, <sup>&#x02217;</sup><italic>p</italic> &#x0003c; 0.05, <sup>&#x02217;&#x02217;</sup><italic>p</italic> &#x0003c; 0.01).</p></caption><graphic xlink:href="fphys-10-00324-g003"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Stereological Estimates of Iba1 and GFAP Load in the Fimbria.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">Sham</th><th valign="top" align="center" rowspan="1" colspan="1">CHORIO</th><th valign="top" align="center" rowspan="1" colspan="1">CHORIO+CXCR2 ANTAG</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Iba1 (&#x003bc;m</bold><sup>3</sup><bold>)</bold></td><td valign="top" align="center" rowspan="1" colspan="1">4.9+1.2 &#x000d7; 10<sup>6</sup></td><td valign="top" align="center" rowspan="1" colspan="1">14.5+1.1 &#x000d7; 10<sup>6&#x02217;&#x02217;</sup></td><td valign="top" align="center" rowspan="1" colspan="1">7.2+0.3 &#x000d7; 10<sup>6&#x02217;</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>GFAP (&#x003bc;m</bold><sup>3</sup><bold>)</bold></td><td valign="top" align="center" rowspan="1" colspan="1">4.1+0.7 &#x000d7; 10<sup>6</sup></td><td valign="top" align="center" rowspan="1" colspan="1">15.1+1.7 &#x000d7; 10<sup>6&#x02217;</sup></td><td valign="top" align="center" rowspan="1" colspan="1">7.7+1.5 &#x000d7; 10<sup>6&#x02217;</sup></td></tr></tbody></table><table-wrap-foot><attrib><italic>Asterix(s) in CHORIO column indicates statistical difference from Sham group. Asterix in CHORIO+CXCR2 ANTAG column indicates statistical difference from CHORIO group. <sup>&#x02217;</sup>p &#x0003c; 0.05, <sup>&#x02217;&#x02217;</sup>p &#x0003c; 0.01.</italic></attrib></table-wrap-foot></table-wrap></sec><sec><title>CXCR2 Blockade During a Critical Postnatal Window Mitigates the Effects of CHORIO and Protects the Developing Brain</title><p>Given the biochemical evidence of reduced neuroinflammation and neural health at P7, and at P21, we next performed DTI analyses to examine the effects of CXCR2 antagonism on white and gray matter microstructure using a translational imaging outcome measure. We began by creating color coded fractional anisotropy (FA) maps and directionally-encoded color diffusion maps (<xref ref-type="fig" rid="F4">Figure 4</xref>). Both color FA and the directionally encoded color diffusion maps depict loss of structural integrity in major white matter tracts, including the corpus callosum, fimbria, external and internal capsule, and demonstrate subsequent improvement with CXCR2 antagonism (<xref ref-type="fig" rid="F4">Figure 4</xref>). Indeed, quantification of diffusion metrics and scalars in corpus callosum (<xref ref-type="fig" rid="F5">Figure 5A&#x02013;C</xref>) and external capsule FA (<xref ref-type="fig" rid="F5">Figure 5D&#x02013;F</xref>), confirms significant loss of microstructural integrity in CHORIO pups that is recovered with CXCR2 antagonism. These changes in FA are also associated with injury-induced elevations in radial diffusivity (RD). Notably, CXCR2 antagonism ameliorated CHORIO-induced elevations in RD in both the corpus callosum and external capsule (<xref ref-type="fig" rid="F5">Figure 5C,F</xref>), and restored axial diffusivity (AD) in the corpus callosum (<xref ref-type="fig" rid="F5">Figure 5B</xref>), consistent with improved white matter and axonal health, and improved structural coherence and directional diffusion. We also examined gray matter microstructure using DTI. Similar to the white matter regions, we found injury induced decreases in hippocampal and thalamic FA in CHORIO pups compared to shams (<italic>n</italic> = 5&#x02013;6/group, <italic>p</italic> &#x0003c; 0.01, <xref ref-type="fig" rid="F6">Figure 6</xref>). Also consistent with white matter regions, administration of SB225002, restored FA in the hippocampus, indicative of improved gray matter microstructure. No changes in RD and AD were noted in the gray matter (data not shown).</p><fig id="F4" position="float"><label>FIGURE 4</label><caption><p>CXCR2 Antagonism Mitigates Abnormalities in Cerebral Diffusion. Following prenatal chorioamnionitis (CHORIO), transient postnatal administration of the CXCR2 antagonist, SB225002, attenuated losses of fractional anisotropy (FA) in major white matter tracts (left, black arrows) on postnatal day 21 (P21). Similarly, directionally encoded color maps (right) reveal loss of diffusion in white and gray matter, including the corpus callosum and anterior hippocampus (white arrows). Color coded FA legend (left) indicates the degree of anisotropy from 0 to 1, with 0 being unrestricted and 1 fully restricted. Directionally color encoded arrows (right) indicate horizontal diffusion (red), anterior to posterior diffusion (blue), and superior-inferior diffusion (green).</p></caption><graphic xlink:href="fphys-10-00324-g004"/></fig><fig id="F5" position="float"><label>FIGURE 5</label><caption><p>CXCR2 Antagonism Attenuates White Matter Microstructural Injury. Following prenatal chorioamnionitis (CHORIO), transient postnatal administration of the CXCR2 antagonist, SB225002, attenuated injury induced changes in fractional anisotropy <bold>(A)</bold> in the corpus callosum at postnatal day 21 (P21), together with mitigating changes in axial (AD, <bold>B</bold>) and radial (RD) diffusion <bold>(C)</bold>. Similarly, CHORIO animals had reduced FA <bold>(D)</bold> and increased RD <bold>(F)</bold> in the external capsule. Treatment with a CXCR2 antagonist significantly improved both FA and RD. No changes were observed in AD <bold>(E)</bold>. (<italic>n</italic> = 5&#x02013;6, two-way ANOVA with Bonferroni&#x02019;s <italic>post hoc</italic> correction, <sup>&#x02217;</sup><italic>p</italic> &#x0003c; 0.05, <sup>&#x02217;&#x02217;</sup><italic>p</italic> &#x0003c; 0.01, <sup>&#x02217;&#x02217;&#x02217;</sup><italic>p</italic> &#x0003c; 0.001).</p></caption><graphic xlink:href="fphys-10-00324-g005"/></fig><fig id="F6" position="float"><label>FIGURE 6</label><caption><p>CXCR2 Antagonism Improves Gray Matter Microstructural Integrity. Following prenatal chorioamnionitis (CHORIO), transient postnatal administration of the CXCR2 antagonist, SB225002, attenuated injury induced changes in fractional anisotropy (FA) in the hippocampus <bold>(A)</bold> at postnatal day 21 (P21). While CHORIO reduced FA in the thalamus, no difference was observed with CXCR2 antagonism in the thalamus <bold>(B)</bold>. (<italic>n</italic> = 5&#x02013;6, two-way ANOVA with Bonferroni&#x02019;s <italic>post hoc</italic> correction, <sup>&#x02217;</sup><italic>p</italic> &#x0003c; 0.05, <sup>&#x02217;&#x02217;</sup><italic>p</italic> &#x0003c; 0.01).</p></caption><graphic xlink:href="fphys-10-00324-g006"/></fig></sec></sec><sec><title>Discussion</title><p>Chemokines, a family of small molecular weight chemotactic cytokines, (<xref rid="B5" ref-type="bibr">Ben-Baruch et al., 1995</xref>; <xref rid="B55" ref-type="bibr">Luster, 1998</xref>; <xref rid="B46" ref-type="bibr">Kielian et al., 2001</xref>) are classically defined by their ability to induce directional migration and activation of leukocytes to areas of inflammation in the body (<xref rid="B46" ref-type="bibr">Kielian et al., 2001</xref>; <xref rid="B78" ref-type="bibr">Semple et al., 2010b</xref>; <xref rid="B82" ref-type="bibr">Veenstra and Ransohoff, 2012</xref>). Chemokine signaling is also integral to development of multiple placental and neural cell lineages. CXCL1 is an ERL (glutamic acid-arginine-leucine) CXC chemokine defined by potent CXCR2 receptor-dependent neutrophil chemoattractant activity, whereas CXC chemokines lacking the ERL motif are inactive toward neutrophils ( <xref rid="B61" ref-type="bibr">Murphy, 1997</xref>; <xref rid="B7" ref-type="bibr">Biondo et al., 2014</xref>). CXCL1 is the dominant CXCR2 ligand expressed in the inflamed CNS (<xref rid="B72" ref-type="bibr">Roy et al., 2012</xref>). CXCL1 transcripts are 4-fold more abundant in the brain than those of CXCL2 and its levels are directly proportional to its function (<xref rid="B72" ref-type="bibr">Roy et al., 2012</xref>). Upregulation of CXCL1/CXCR2 signaling is central to neuroinflammation following exposure to bacterial endotoxin, (<xref rid="B46" ref-type="bibr">Kielian et al., 2001</xref>; <xref rid="B14" ref-type="bibr">Carlson et al., 2008</xref>; <xref rid="B45" ref-type="bibr">Kerstetter et al., 2009</xref>; <xref rid="B53" ref-type="bibr">Liu et al., 2010</xref>; <xref rid="B72" ref-type="bibr">Roy et al., 2012</xref>) and CXCL1 is rapidly upregulated in traumatic brain injury (TBI), Alzheimer&#x02019;s disease, multiple sclerosis, chronic pain and stroke, and is followed by neural cell specific increases in CXCR2 expression (<xref rid="B81" ref-type="bibr">Valles et al., 2006</xref>; <xref rid="B51" ref-type="bibr">Lindner et al., 2008</xref>; <xref rid="B45" ref-type="bibr">Kerstetter et al., 2009</xref>; <xref rid="B53" ref-type="bibr">Liu et al., 2010</xref>, <xref rid="B52" ref-type="bibr">2015</xref>; <xref rid="B12" ref-type="bibr">Cao et al., 2014</xref>; <xref rid="B19" ref-type="bibr">Connell et al., 2015</xref>; <xref rid="B73" ref-type="bibr">Ryu et al., 2015</xref>). Indeed, CXCR2 expression is essential for cerebral endothelial activation and leukocyte recruitment, (<xref rid="B85" ref-type="bibr">Wu et al., 2015</xref>) with CXCR2 antagonism or CXCL1 deficiency mitigating neutrophil infiltration and recruitment into brain parenchyma (<xref rid="B85" ref-type="bibr">Wu et al., 2015</xref>). In alignment with these data and with clinical literature confirming that PBI in preterm infants often originates <italic>in utero</italic>, the present investigation supports the hypothesis that CXCL1/CXCR2 signaling negatively impacts brain development. Importantly, here we show CXCR2 blockade reversed injury-induced CNS elevations in neuron-specific alpha-II spectrin cleavage, an established biomarker of PBI (<xref rid="B38" ref-type="bibr">Jantzie et al., 2014b</xref>, <xref rid="B42" ref-type="bibr">2016</xref>). CXCR2 blockade also mitigated connexin43 expression, a hemichannel and gap junction protein connected to CXCR2 activation, astrocyte activation, and excitotoxicity (<xref rid="B79" ref-type="bibr">Theodoric et al., 2012</xref>; <xref rid="B17" ref-type="bibr">Chen et al., 2014</xref>; <xref rid="B90" ref-type="bibr">Yin et al., 2018</xref>). Interestingly, activated astrocytes can release CXCL1 and facilitate CXCR2 signal transduction via connexin43 to enhance and feed forward neuroinflammation (<xref rid="B12" ref-type="bibr">Cao et al., 2014</xref>; <xref rid="B17" ref-type="bibr">Chen et al., 2014</xref>, <xref rid="B16" ref-type="bibr">2018</xref>). Similarly, here CXCR2 blockade attenuated white matter loss and axonal injury and mitigated CHORIO-induced increases in Iba1 and GFAP expression, and provided sustained protection to white and gray matter microstructure 4 weeks following <italic>in utero</italic> exposure to CHORIO. These data validate CXCR2 blockade and a putative functional relationship between CXCL1/CXCR2 and neural injury <italic>in vivo</italic>, and support the hypothesis that CXCL1/CXCR2 signaling is a prominent mediator of inflammation through the placental-fetal-brain axis. Moreover, we provide first evidence of the primacy of excess CXCR2 activation in white and gray matter neural injury that hallmarks PBI.</p><p>Prior preclinical reports confirm that CXCR2 blockade may be beneficial in the mature CNS. CXCR2 is dysregulated on OPCs and monocytes/microglia during demyelination (<xref rid="B51" ref-type="bibr">Lindner et al., 2008</xref>). On neurons, CXCL1 induction sustains late-phase neuropathic pain by activating CXCR2, and modulates synaptic transmission (<xref rid="B17" ref-type="bibr">Chen et al., 2014</xref>). Blockade of CXCR2 with the same inhibitor used here, SB225002, reverses allodynia and suppresses injury-induced increases in neuronal firing frequency, confirming a role for CXCL1/CXCR2 in synaptic plasticity (<xref rid="B17" ref-type="bibr">Chen et al., 2014</xref>). In TBI and stroke, cerebral CXCL1/CXCR2 levels determine the magnitude of neutrophil infiltration, subsequent neuronal loss, and infarct volume (<xref rid="B77" ref-type="bibr">Semple et al., 2010a</xref>; <xref rid="B32" ref-type="bibr">Hennessy et al., 2015</xref>). Here, we show that CXCR2 blockade during a critical postnatal window reverses some of the key biochemical and imaging hallmarks of CHORIO through P21 and protects the developing brain from excess CXCR2 signaling. Together, with high-resolution DTI confirming that CXCR2 blockade also reduced microstructural white and gray matter injury and resolves pathological changes in diffusion, these data emphasize the role of CXCL1/CXCR2 signaling in PBI defined by <italic>in utero</italic> inflammation and for the first time report the putative efficacy of transient CXCR2 blockade in the developing brain. Interestingly, numerous studies in adult animals emphasize that blocking chemokine receptors such as CXCR2, rather than individual ligands such as CXCL1, is most effective for neural repair (<xref rid="B77" ref-type="bibr">Semple et al., 2010a</xref>,<xref rid="B78" ref-type="bibr">b</xref>; <xref rid="B82" ref-type="bibr">Veenstra and Ransohoff, 2012</xref>). While commonly used, CXCR2 knockout (KO) mice have drawbacks including lymph node enlargement and myelination defects, (<xref rid="B80" ref-type="bibr">Tsai et al., 2002</xref>; <xref rid="B13" ref-type="bibr">Cardona et al., 2008</xref>; <xref rid="B77" ref-type="bibr">Semple et al., 2010a</xref>,<xref rid="B78" ref-type="bibr">b</xref>) emphasizing the fundamental role for CXCR2 in normal physiology and neurodevelopment. We hypothesized that rather than complete CXCR2 silence throughout development, transient loss of excessive CXCR2 signaling following CHORIO would mitigate brain injury. Additional dose-response and duration-response studies beyond the scope here are needed to clarify the optimal dosing regimen for SB225002. Indeed, a gradient effect may be promising for therapeutics targeting CXCL1/CXCR2 because it suggests partial receptor inhibition may be sufficient to attenuate neutrophil activation and improve neural health without complete cessation of essential biological processes that may cause additional detrimental effects in the developing injured brain (<xref rid="B2" ref-type="bibr">Abdulkadir et al., 2010</xref>; <xref rid="B77" ref-type="bibr">Semple et al., 2010a</xref>).</p><p>Infants with CHORIO have elevated neutrophil and monocyte counts compared to infants without intra-amniotic infection, (<xref rid="B84" ref-type="bibr">Weitkamp et al., 2016</xref>) emphasizing compartment-specific modulation of cytokines and immune cell diversity in CHORIO. Previously, we have shown that elevated placental CXCL1 is associated with acute neutrophilia and immune cell activation in the placenta, and with neutrophilia, immune cell activation and microgliosis in the brain (<xref rid="B34" ref-type="bibr">Jantzie et al., 2014a</xref>; <xref rid="B57" ref-type="bibr">Maxwell et al., 2015</xref>; <xref rid="B89" ref-type="bibr">Yellowhair et al., 2018</xref>). Using flow cytometry, we also demonstrated increased CXCR2<sup>+</sup> neutrophils in the placenta and brain following CHORIO (<xref rid="B89" ref-type="bibr">Yellowhair et al., 2018</xref>). Here, we show that CXCR2 blockade attenuates neutrophil activation in the brain at P7. Together with prior publications confirming a sustained neuroinflammatory response following CHORIO, hallmarked by upregulated CXCL1, and increased microglia and macrophages, (<xref rid="B34" ref-type="bibr">Jantzie et al., 2014a</xref>; <xref rid="B57" ref-type="bibr">Maxwell et al., 2015</xref>; <xref rid="B89" ref-type="bibr">Yellowhair et al., 2018</xref>) these data indicate that CXCR2 antagonism reduces GFAP and Iba1 immunoreactivity consistent with changes to microglia and astrocytes. While future investigations will examine microglial activation state and regional and temporal changes in glial morphology and number, these data are consistent with earlier reports demonstrating that cerebral CXCL1 and CXCR2 levels determine the magnitude of neutrophil infiltration, subsequent neuronal loss, gliosis and infarct volume in stroke and TBI (<xref rid="B77" ref-type="bibr">Semple et al., 2010a</xref>; <xref rid="B32" ref-type="bibr">Hennessy et al., 2015</xref>). Typically, neutrophil influx is a secondary response after injury, and further exacerbates acute endogenous brain inflammation mediated by microglia (<xref rid="B27" ref-type="bibr">Gelderblom et al., 2009</xref>; <xref rid="B43" ref-type="bibr">Jellema et al., 2013</xref>). Indeed, limiting neutrophil and macrophage infiltration improves neuropathological and functional outcomes in models of stroke and TBI (<xref rid="B77" ref-type="bibr">Semple et al., 2010a</xref>; <xref rid="B59" ref-type="bibr">Morganti et al., 2015</xref>). In preterm sheep with hypoxia-ischemia, neutrophils invade vulnerable brain regions, including hippocampus, periventricular and subcortical white matter, (<xref rid="B43" ref-type="bibr">Jellema et al., 2013</xref>) with mobilization and recruitment accompanied by prominent microgliosis (<xref rid="B62" ref-type="bibr">Raivich et al., 1999</xref>; <xref rid="B81" ref-type="bibr">Valles et al., 2006</xref>). Indeed, CXCR2 expression on neural cells is essential for cerebral endothelial activation and leukocyte recruitment, (<xref rid="B85" ref-type="bibr">Wu et al., 2015</xref>) with CXCR2 antagonism or CXCL1 deficiency mitigating neutrophil infiltration and recruitment into brain parenchyma, as well as microgliosis (<xref rid="B85" ref-type="bibr">Wu et al., 2015</xref>).</p><p>Despite including both sexes in all outcome measures of this study, we were underpowered to detect sex differences. Future investigations beyond the scope of the present study should include assessments at later time points with translational measures of behavior and function consistent with previous reports (<xref rid="B40" ref-type="bibr">Jantzie et al., 2018</xref>; <xref rid="B71" ref-type="bibr">Robinson et al., 2018</xref>). Another limitation is the dosing regimen of SB225002, and the duration and timing of dose-response will be the focus of future studies, as well as a complete neuropathological examination and with spatiotemporal regional assessment of oligodendrocyte, neuron, astrocyte and microglial number. Glial activation state and morphology should also be assessed rigorously. In conclusion, this is the first report that transient postnatal blockade of CXCR2 modulates PBI pathophysiology and attenuates neural injury following CHORIO. Moreover, we provide the first evidence of the primacy of excess CXCR2 activation in white and gray matter neural injury that hallmarks PBI. While blocking microglial activation, neutrophil activation and inflammatory signaling is beneficial after CHORIO, the homeostatic control of chemokine signaling during development, injury, and repair cannot be overemphasized. The blockade of receptors essential for normal physiological properties, such as CXCR2, warrants further investigation.</p></sec><sec sec-type="data-availability"><title>Data Availability</title><p>All datasets generated for this study are included in the manuscript and/or the supplementary files.</p></sec><sec><title>Author Contributions</title><p>LJ conceptualized the hypothesis, and supervised the experiments. TY, JN, SN, JM, EM, SR, and LJ designed and performed the experiments. SR and LJ interpreted the data. LJ and TY wrote the manuscript. All authors contributed to manuscript revision and approved the final version.</p></sec><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This study was supported by generous funding from the National Institutes of Health 1R01HL139492 to LJ and 1S10OD021598 for 7T MRI resources at the University of New Mexico.</p></fn></fn-group><ack><p>The authors are most grateful for the exceptional MRI expertise of Yirong Yang, Ph.D.</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbadie</surname><given-names>C.</given-names></name><name><surname>Bhangoo</surname><given-names>S.</given-names></name><name><surname>De Koninck</surname><given-names>Y.</given-names></name><name><surname>Malcangio</surname><given-names>M.</given-names></name><name><surname>Melik-Parsadaniantz</surname><given-names>S.</given-names></name><name><surname>White</surname><given-names>F. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Chemokines and pain mechanisms.</article-title>
<source><italic>Brain Res. Rev.</italic></source>
<volume>60</volume>
<fpage>125</fpage>&#x02013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresrev.2008.12.002</pub-id>
<pub-id pub-id-type="pmid">19146875</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdulkadir</surname><given-names>A. A.</given-names></name><name><surname>Kimimasa</surname><given-names>T.</given-names></name><name><surname>Bell</surname><given-names>M. J.</given-names></name><name><surname>Macpherson</surname><given-names>T. A.</given-names></name><name><surname>Keller</surname><given-names>B. B.</given-names></name><name><surname>Yanowitz</surname><given-names>T. D.</given-names></name></person-group> (<year>2010</year>). <article-title>Placental inflammation and fetal hemodynamics in a rat model of chorioamnionitis.</article-title>
<source><italic>Pediatr. Res.</italic></source>
<volume>68</volume>
<fpage>513</fpage>&#x02013;<lpage>518</lpage>. <pub-id pub-id-type="doi">10.1203/PDR.0b013e3181f851ed</pub-id>
<pub-id pub-id-type="pmid">20736882</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anblagan</surname><given-names>D.</given-names></name><name><surname>Pataky</surname><given-names>R.</given-names></name><name><surname>Evans</surname><given-names>M. J.</given-names></name><name><surname>Telford</surname><given-names>E. J.</given-names></name><name><surname>Serag</surname><given-names>A.</given-names></name><name><surname>Sparrow</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Association between preterm brain injury and exposure to chorioamnionitis during fetal life.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>6</volume>:<issue>37932</issue>. <pub-id pub-id-type="doi">10.1038/srep37932</pub-id>
<pub-id pub-id-type="pmid">27905410</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastek</surname><given-names>J. A.</given-names></name><name><surname>Brown</surname><given-names>A. G.</given-names></name><name><surname>Anton</surname><given-names>L.</given-names></name><name><surname>Srinivas</surname><given-names>S. K.</given-names></name><name><surname>D&#x02019;Addio</surname><given-names>A.</given-names></name><name><surname>Elovitz</surname><given-names>M. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Biomarkers of inflammation and placental dysfunction are associated with subsequent preterm birth.</article-title>
<source><italic>J. Matern. Fetal Neonat. Med.</italic></source>
<volume>24</volume>
<fpage>600</fpage>&#x02013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2010.511340</pub-id>
<pub-id pub-id-type="pmid">20822327</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Baruch</surname><given-names>A.</given-names></name><name><surname>Michiel</surname><given-names>D. F.</given-names></name><name><surname>Oppenheim</surname><given-names>J. J.</given-names></name></person-group> (<year>1995</year>). <article-title>Signals and receptors involved in recruitment of inflammatory cells.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>270</volume>
<fpage>11703</fpage>&#x02013;<lpage>11706</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.270.20.11703</pub-id><pub-id pub-id-type="pmid">7744810</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergeron</surname><given-names>J.</given-names></name><name><surname>Gerges</surname><given-names>N.</given-names></name><name><surname>Guiraut</surname><given-names>C.</given-names></name><name><surname>Grbic</surname><given-names>D.</given-names></name><name><surname>Allard</surname><given-names>M. J.</given-names></name><name><surname>Fortier</surname><given-names>L. C.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Activation of the IL-1beta/CXCL1/MMP-10 axis in chorioamnionitis induced by inactivated group B <italic>Streptococcus</italic>.</article-title>
<source><italic>Placenta</italic></source>
<volume>47</volume>
<fpage>116</fpage>&#x02013;<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/j.placenta.2016.09.016</pub-id>
<pub-id pub-id-type="pmid">27780533</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biondo</surname><given-names>C.</given-names></name><name><surname>Mancuso</surname><given-names>G.</given-names></name><name><surname>Midiri</surname><given-names>A.</given-names></name><name><surname>Signorino</surname><given-names>G.</given-names></name><name><surname>Domina</surname><given-names>M.</given-names></name><name><surname>Lanza Cariccio</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>The interleukin-1beta/CXCL1/2/neutrophil axis mediates host protection against group B streptococcal infection.</article-title>
<source><italic>Infect. Immun.</italic></source>
<volume>82</volume>
<fpage>4508</fpage>&#x02013;<lpage>4517</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.02104-2114</pub-id>
<pub-id pub-id-type="pmid">25114117</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blencowe</surname><given-names>H.</given-names></name><name><surname>Cousens</surname><given-names>S.</given-names></name><name><surname>Oestergaard</surname><given-names>M. Z.</given-names></name><name><surname>Chou</surname><given-names>D.</given-names></name><name><surname>Moller</surname><given-names>A. B.</given-names></name><name><surname>Narwal</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications.</article-title>
<source><italic>Lancet</italic></source>
<volume>379</volume>
<fpage>2162</fpage>&#x02013;<lpage>2172</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(12)60820-4</pub-id>
<pub-id pub-id-type="pmid">22682464</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blencowe</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>A. C.</given-names></name><name><surname>Cousens</surname><given-names>S.</given-names></name><name><surname>Bahalim</surname><given-names>A.</given-names></name><name><surname>Narwal</surname><given-names>R.</given-names></name><name><surname>Zhong</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Preterm birth-associated neurodevelopmental impairment estimates at regional and global levels for 2010.</article-title>
<source><italic>Pediatr. Res.</italic></source>
<volume>74</volume>(Suppl. 1), <fpage>17</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2013.204</pub-id>
<pub-id pub-id-type="pmid">24366461</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boardman</surname><given-names>J. P.</given-names></name><name><surname>Craven</surname><given-names>C.</given-names></name><name><surname>Valappil</surname><given-names>S.</given-names></name><name><surname>Counsell</surname><given-names>S. J.</given-names></name><name><surname>Dyet</surname><given-names>L. E.</given-names></name><name><surname>Rueckert</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>A common neonatal image phenotype predicts adverse neurodevelopmental outcome in children born preterm.</article-title>
<source><italic>Neuroimage</italic></source>
<volume>52</volume>
<fpage>409</fpage>&#x02013;<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.04.261</pub-id>
<pub-id pub-id-type="pmid">20451627</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bry</surname><given-names>K. J.</given-names></name><name><surname>Jacobsson</surname><given-names>B.</given-names></name><name><surname>Nilsson</surname><given-names>S.</given-names></name><name><surname>Bry</surname><given-names>K.</given-names></name></person-group> (<year>2015</year>). <article-title>Gastric fluid cytokines are associated with chorioamnionitis and white blood cell counts in preterm infants.</article-title>
<source><italic>Acta paediatr.</italic></source>
<volume>104</volume>
<fpage>575</fpage>&#x02013;<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1111/apa.12947</pub-id>
<pub-id pub-id-type="pmid">25640274</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>D. L.</given-names></name><name><surname>Zhang</surname><given-names>Z. J.</given-names></name><name><surname>Xie</surname><given-names>R. G.</given-names></name><name><surname>Jiang</surname><given-names>B. C.</given-names></name><name><surname>Ji</surname><given-names>R. R.</given-names></name><name><surname>Gao</surname><given-names>Y. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2.</article-title>
<source><italic>Exp. Neurol.</italic></source>
<volume>261</volume>
<fpage>328</fpage>&#x02013;<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2014.05.014</pub-id>
<pub-id pub-id-type="pmid">24852102</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardona</surname><given-names>A. E.</given-names></name><name><surname>Sasse</surname><given-names>M. E.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Cardona</surname><given-names>S. M.</given-names></name><name><surname>Mizutani</surname><given-names>M.</given-names></name><name><surname>Savarin</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues.</article-title>
<source><italic>Blood</italic></source>
<volume>112</volume>
<fpage>256</fpage>&#x02013;<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2007-10-118497</pub-id>
<pub-id pub-id-type="pmid">18347198</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>T.</given-names></name><name><surname>Kroenke</surname><given-names>M.</given-names></name><name><surname>Rao</surname><given-names>P.</given-names></name><name><surname>Lane</surname><given-names>T. E.</given-names></name><name><surname>Segal</surname><given-names>B.</given-names></name></person-group> (<year>2008</year>). <article-title>The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease.</article-title>
<source><italic>J. Exp. Med.</italic></source>
<volume>205</volume>
<fpage>811</fpage>&#x02013;<lpage>823</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20072404</pub-id>
<pub-id pub-id-type="pmid">18347102</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chau</surname><given-names>V.</given-names></name><name><surname>McFadden</surname><given-names>D. E.</given-names></name><name><surname>Poskitt</surname><given-names>K. J.</given-names></name><name><surname>Miller</surname><given-names>S. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Chorioamnionitis in the pathogenesis of brain injury in preterm infants.</article-title>
<source><italic>Clin. Perinatol.</italic></source>
<volume>41</volume>
<fpage>83</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/j.clp.2013.10.009</pub-id>
<pub-id pub-id-type="pmid">24524448</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Qadri</surname><given-names>M. Y.</given-names></name><name><surname>Berta</surname><given-names>T.</given-names></name><name><surname>Ji</surname><given-names>R. R.</given-names></name></person-group> (<year>2018</year>). <article-title>Sex-dependent glial signaling in pathological pain: distinct roles of spinal microglia and astrocytes.</article-title>
<source><italic>Neurosci. Bull.</italic></source>
<volume>34</volume>
<fpage>98</fpage>&#x02013;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1007/s12264-017-0145-y</pub-id>
<pub-id pub-id-type="pmid">28585113</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Park</surname><given-names>C. K.</given-names></name><name><surname>Xie</surname><given-names>R. G.</given-names></name><name><surname>Berta</surname><given-names>T.</given-names></name><name><surname>Nedergaard</surname><given-names>M.</given-names></name><name><surname>Ji</surname><given-names>R. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice.</article-title>
<source><italic>Brain</italic></source>
<volume>137</volume>
<fpage>2193</fpage>&#x02013;<lpage>2209</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awu140</pub-id>
<pub-id pub-id-type="pmid">24919967</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J.</given-names></name><name><surname>Ghezzi</surname><given-names>F.</given-names></name><name><surname>Romero</surname><given-names>R.</given-names></name><name><surname>Ghidini</surname><given-names>A.</given-names></name><name><surname>Mazor</surname><given-names>M.</given-names></name><name><surname>Tolosa</surname><given-names>J. E.</given-names></name><etal/></person-group> (<year>1996</year>). <article-title>GRO alpha in the fetomaternal and amniotic fluid compartments during pregnancy and parturition.</article-title>
<source><italic>Am. J. Reprod. Immunol.</italic></source>
<volume>35</volume>
<fpage>23</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0897.1996.tb00004.x</pub-id>
<pub-id pub-id-type="pmid">8789556</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connell</surname><given-names>B.</given-names></name><name><surname>Gordon</surname><given-names>J.</given-names></name><name><surname>Saleh</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>ELR-CXC chemokine antagonism is neuroprotective in a rat model of ischemic stroke.</article-title>
<source><italic>Neurosci. Lett.</italic></source>
<volume>606</volume>
<fpage>117</fpage>&#x02013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2015.08.041</pub-id>
<pub-id pub-id-type="pmid">26320021</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Counsell</surname><given-names>S. J.</given-names></name><name><surname>Edwards</surname><given-names>A. D.</given-names></name><name><surname>Chew</surname><given-names>A. T.</given-names></name><name><surname>Anjari</surname><given-names>M.</given-names></name><name><surname>Dyet</surname><given-names>L. E.</given-names></name><name><surname>Srinivasan</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Specific relations between neurodevelopmental abilities and white matter microstructure in children born preterm.</article-title>
<source><italic>Brain</italic></source>
<volume>131</volume>
<fpage>3201</fpage>&#x02013;<lpage>3208</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awn268</pub-id>
<pub-id pub-id-type="pmid">18952670</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dammann</surname><given-names>O.</given-names></name><name><surname>Leviton</surname><given-names>A.</given-names></name></person-group> (<year>1997</year>). <article-title>Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn.</article-title>
<source><italic>Pediatr. Res.</italic></source>
<volume>42</volume>
<fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1203/00006450-199707000-199707001</pub-id><pub-id pub-id-type="pmid">9212029</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dammann</surname><given-names>O.</given-names></name><name><surname>Leviton</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Intermittent or sustained systemic inflammation and the preterm brain.</article-title>
<source><italic>Pediatr. Res.</italic></source>
<volume>75</volume>
<fpage>376</fpage>&#x02013;<lpage>380</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2013.238</pub-id>
<pub-id pub-id-type="pmid">24429547</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunk</surname><given-names>C. E.</given-names></name><name><surname>Gellhaus</surname><given-names>A.</given-names></name><name><surname>Drewlo</surname><given-names>S.</given-names></name><name><surname>Baczyk</surname><given-names>D.</given-names></name><name><surname>Potgens</surname><given-names>A. J.</given-names></name><name><surname>Winterhager</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>The molecular role of connexin 43 in human trophoblast cell fusion.</article-title>
<source><italic>Biol. Reprod.</italic></source>
<volume>86</volume>:<issue>115</issue>
<pub-id pub-id-type="doi">10.1095/biolreprod.111.096925</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fant</surname><given-names>M. E.</given-names></name><name><surname>Fuentes</surname><given-names>J.</given-names></name><name><surname>Kong</surname><given-names>X.</given-names></name><name><surname>Jackman</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>The nexus of prematurity, birth defects, and intrauterine growth restriction: a role for plac1-regulated pathways.</article-title>
<source><italic>Front. Pediatr.</italic></source>
<volume>2</volume>:<issue>8</issue>. <pub-id pub-id-type="doi">10.3389/fped.2014.00008</pub-id>
<pub-id pub-id-type="pmid">24600606</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filipovic</surname><given-names>R.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Zecevic</surname><given-names>N.</given-names></name></person-group> (<year>2003</year>). <article-title>GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions.</article-title>
<source><italic>Dev. Neurosci.</italic></source>
<volume>25</volume>
<fpage>279</fpage>&#x02013;<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1159/000072275</pub-id>
<pub-id pub-id-type="pmid">12966224</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galinsky</surname><given-names>R.</given-names></name><name><surname>Polglase</surname><given-names>G. R.</given-names></name><name><surname>Hooper</surname><given-names>S. B.</given-names></name><name><surname>Black</surname><given-names>M. J.</given-names></name><name><surname>Moss</surname><given-names>T. J.</given-names></name></person-group> (<year>2013</year>). <article-title>The consequences of chorioamnionitis: preterm birth and effects on development.</article-title>
<source><italic>J. Pregnancy</italic></source>
<volume>2013</volume>:<issue>412831</issue>. <pub-id pub-id-type="doi">10.1155/2013/412831</pub-id>
<pub-id pub-id-type="pmid">23533760</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelderblom</surname><given-names>M.</given-names></name><name><surname>Leypoldt</surname><given-names>F.</given-names></name><name><surname>Steinbach</surname><given-names>K.</given-names></name><name><surname>Behrens</surname><given-names>D.</given-names></name><name><surname>Choe</surname><given-names>C. U.</given-names></name><name><surname>Siler</surname><given-names>D. A.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Temporal and spatial dynamics of cerebral immune cell accumulation in stroke.</article-title>
<source><italic>Stroke</italic></source>
<volume>40</volume>
<fpage>1849</fpage>&#x02013;<lpage>1857</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.108.534503</pub-id>
<pub-id pub-id-type="pmid">19265055</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldenberg</surname><given-names>R. L.</given-names></name><name><surname>Hauth</surname><given-names>J. C.</given-names></name><name><surname>Andrews</surname><given-names>W. W.</given-names></name></person-group> (<year>2000</year>). <article-title>Intrauterine infection and preterm delivery.</article-title>
<source><italic>N. Engl. J. Med.</italic></source>
<volume>342</volume>
<fpage>1500</fpage>&#x02013;<lpage>1507</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM200005183422007</pub-id>
<pub-id pub-id-type="pmid">10816189</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gundersen</surname><given-names>H. J.</given-names></name><name><surname>Bagger</surname><given-names>P.</given-names></name><name><surname>Bendtsen</surname><given-names>T. F.</given-names></name><name><surname>Evans</surname><given-names>S. M.</given-names></name><name><surname>Korbo</surname><given-names>L.</given-names></name><name><surname>Marcussen</surname><given-names>N.</given-names></name><etal/></person-group> (<year>1988</year>). <article-title>The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis.</article-title>
<source><italic>APMIS</italic></source>
<volume>96</volume>
<fpage>857</fpage>&#x02013;<lpage>881</lpage>. <pub-id pub-id-type="doi">10.1111/j.1699-0463.1988.tb00954.x</pub-id>
<pub-id pub-id-type="pmid">3056461</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagberg</surname><given-names>H.</given-names></name><name><surname>Mallard</surname><given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>Effect of inflammation on central nervous system development and vulnerability.</article-title>
<source><italic>Curr. Opin. Neurol.</italic></source>
<volume>18</volume>
<fpage>117</fpage>&#x02013;<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1097/01.wco.0000162851.44897.8f</pub-id><pub-id pub-id-type="pmid">15791140</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagberg</surname><given-names>H.</given-names></name><name><surname>Mallard</surname><given-names>C.</given-names></name><name><surname>Ferriero</surname><given-names>D. M.</given-names></name><name><surname>Vannucci</surname><given-names>S. J.</given-names></name><name><surname>Levison</surname><given-names>S. W.</given-names></name><name><surname>Vexler</surname><given-names>Z. S.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>The role of inflammation in perinatal brain injury.</article-title>
<source><italic>Nat. Rev. Neurol.</italic></source>
<volume>11</volume>
<fpage>192</fpage>&#x02013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2015.13</pub-id>
<pub-id pub-id-type="pmid">25686754</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hennessy</surname><given-names>E.</given-names></name><name><surname>Griffin</surname><given-names>E. W.</given-names></name><name><surname>Cunningham</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Astrocytes are primed by chronic neurodegeneration to produce exaggerated chemokine and cell infiltration responses to acute stimulation with the cytokines IL-1beta and TNF-alpha.</article-title>
<source><italic>J. Neurosci.</italic></source>
<volume>35</volume>
<fpage>8411</fpage>&#x02013;<lpage>8422</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2745-14.2015</pub-id>
<pub-id pub-id-type="pmid">26041910</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>C. D.</given-names></name><name><surname>Meaddough</surname><given-names>E.</given-names></name><name><surname>Aversa</surname><given-names>K.</given-names></name><name><surname>Copel</surname><given-names>J. A.</given-names></name></person-group> (<year>1998</year>). <article-title>The role of amniotic fluid L-selectin, GRO-alpha, and interleukin-8 in the pathogenesis of intraamniotic infection.</article-title>
<source><italic>Am. J. Obstetr. Gynecol.</italic></source>
<volume>178</volume>
<fpage>428</fpage>&#x02013;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9378(98)70414-4</pub-id>
<pub-id pub-id-type="pmid">9539502</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jantzie</surname><given-names>L. L.</given-names></name><name><surname>Corbett</surname><given-names>C. J.</given-names></name><name><surname>Berglass</surname><given-names>J.</given-names></name><name><surname>Firl</surname><given-names>D. J.</given-names></name><name><surname>Flores</surname><given-names>J.</given-names></name><name><surname>Mannix</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2014a</year>). <article-title>Complex pattern of interaction between in utero hypoxia-ischemia and intra-amniotic inflammation disrupts brain development and motor function.</article-title>
<source><italic>J. Neuroinflamm.</italic></source>
<volume>11</volume>:<issue>131</issue>. <pub-id pub-id-type="doi">10.1186/1742-2094-11-131</pub-id>
<pub-id pub-id-type="pmid">25082427</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jantzie</surname><given-names>L. L.</given-names></name><name><surname>Corbett</surname><given-names>C. J.</given-names></name><name><surname>Firl</surname><given-names>D. J.</given-names></name><name><surname>Robinson</surname><given-names>S.</given-names></name></person-group> (<year>2015a</year>). <article-title>Postnatal erythropoietin mitigates impaired cerebral cortical development following subplate loss from prenatal hypoxia-ischemia.</article-title>
<source><italic>Cereb. Cortex</italic></source>
<volume>25</volume>
<fpage>2683</fpage>&#x02013;<lpage>2695</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhu066</pub-id>
<pub-id pub-id-type="pmid">24722771</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jantzie</surname><given-names>L. L.</given-names></name><name><surname>Getsy</surname><given-names>P.</given-names></name><name><surname>Denson</surname><given-names>J. L.</given-names></name><name><surname>Firl</surname><given-names>D. J.</given-names></name><name><surname>Wilson</surname><given-names>C. G.</given-names></name><name><surname>Robinson</surname><given-names>S.</given-names></name></person-group> (<year>2015b</year>). <article-title>Prenatal hypoxia-ischemia induces potassium chloride cotransporter 2 loss and abnormalities in inhibitory tone.</article-title>
<source><italic>Front. Cell Neurosci.</italic></source>
<volume>3</volume>:<issue>347</issue>.</mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jantzie</surname><given-names>L. L.</given-names></name><name><surname>Talos</surname><given-names>D. M.</given-names></name><name><surname>Jackson</surname><given-names>M. C.</given-names></name><name><surname>Park</surname><given-names>H. K.</given-names></name><name><surname>Graham</surname><given-names>D. A.</given-names></name><name><surname>Lechpammer</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2015c</year>). <article-title>Developmental expression of N-Methyl-d-aspartate (n.d.) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain.</article-title>
<source><italic>Cereb. Cortex</italic></source>
<volume>25</volume>
<fpage>482</fpage>&#x02013;<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bht246</pub-id>
<pub-id pub-id-type="pmid">24046081</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jantzie</surname><given-names>L. L.</given-names></name><name><surname>Getsy</surname><given-names>P. M.</given-names></name><name><surname>Firl</surname><given-names>D. J.</given-names></name><name><surname>Wilson</surname><given-names>C. G.</given-names></name><name><surname>Miller</surname><given-names>R. H.</given-names></name><name><surname>Robinson</surname><given-names>S.</given-names></name></person-group> (<year>2014b</year>). <article-title>Erythropoietin attenuates loss of potassium chloride co-transporters following prenatal brain injury.</article-title>
<source><italic>Mol. Cell. Neurosci.</italic></source>
<volume>61</volume>
<fpage>152</fpage>&#x02013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2014.06.009</pub-id>
<pub-id pub-id-type="pmid">24983520</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jantzie</surname><given-names>L. L.</given-names></name><name><surname>Miller</surname><given-names>R. H.</given-names></name><name><surname>Robinson</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic-ischemic brain injury.</article-title>
<source><italic>Pediatr. Res.</italic></source>
<volume>74</volume>
<fpage>658</fpage>&#x02013;<lpage>667</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2013.155</pub-id>
<pub-id pub-id-type="pmid">24108187</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jantzie</surname><given-names>L. L.</given-names></name><name><surname>Oppong</surname><given-names>A. Y.</given-names></name><name><surname>Conteh</surname><given-names>F. S.</given-names></name><name><surname>Yellowhair</surname><given-names>T. R.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Fink</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Extended neonatal erythropoietin and melatonin combinatorial treatment provides enduring repair of functional deficits in a rat model of cerebral palsy.</article-title>
<source><italic>Front. Neurol.</italic></source>
<volume>13</volume>:<issue>233</issue>
<pub-id pub-id-type="doi">10.3389/fneur.2018.00233</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jantzie</surname><given-names>L. L.</given-names></name><name><surname>Robinson</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Preclinical models of encephalopathy of prematurity.</article-title>
<source><italic>Dev. Neurosci.</italic></source>
<volume>37</volume>
<fpage>277</fpage>&#x02013;<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1159/000371721</pub-id>
<pub-id pub-id-type="pmid">25722056</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jantzie</surname><given-names>L. L.</given-names></name><name><surname>Winer</surname><given-names>J. L.</given-names></name><name><surname>Corbett</surname><given-names>C. J.</given-names></name><name><surname>Robinson</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Erythropoietin modulates cerebral and serum degradation products from excess calpain activation following prenatal hypoxia-ischemia.</article-title>
<source><italic>Dev. Neurosci.</italic></source>
<volume>38</volume>
<fpage>15</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1159/000441024</pub-id>
<pub-id pub-id-type="pmid">26551007</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jellema</surname><given-names>R. K.</given-names></name><name><surname>Lima Passos</surname><given-names>V.</given-names></name><name><surname>Zwanenburg</surname><given-names>A.</given-names></name><name><surname>Ophelders</surname><given-names>D. R.</given-names></name><name><surname>De Munter</surname><given-names>S.</given-names></name><name><surname>Vanderlocht</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Cerebral inflammation and mobilization of the peripheral immune system following global hypoxia-ischemia in preterm sheep.</article-title>
<source><italic>J. Neuroinflamm.</italic></source>
<volume>10</volume>:<issue>13</issue>. <pub-id pub-id-type="doi">10.1186/1742-2094-10-13</pub-id>
<pub-id pub-id-type="pmid">23347579</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallapur</surname><given-names>S. G.</given-names></name><name><surname>Presicce</surname><given-names>P.</given-names></name><name><surname>Rueda</surname><given-names>C. M.</given-names></name><name><surname>Jobe</surname><given-names>A. H.</given-names></name><name><surname>Chougnet</surname><given-names>C. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Fetal immune response to chorioamnionitis.</article-title>
<source><italic>Semin. Reprod. Med.</italic></source>
<volume>32</volume>
<fpage>56</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1055/s-0033-1361823</pub-id>
<pub-id pub-id-type="pmid">24390922</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerstetter</surname><given-names>A. E.</given-names></name><name><surname>Padovani-Claudio</surname><given-names>D. A.</given-names></name><name><surname>Bai</surname><given-names>L.</given-names></name><name><surname>Miller</surname><given-names>R. H.</given-names></name></person-group> (<year>2009</year>). <article-title>Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis.</article-title>
<source><italic>Exp. Neurol.</italic></source>
<volume>220</volume>
<fpage>44</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2009.07.010</pub-id>
<pub-id pub-id-type="pmid">19616545</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kielian</surname><given-names>T.</given-names></name><name><surname>Barry</surname><given-names>B.</given-names></name><name><surname>Hickey</surname><given-names>W. F.</given-names></name></person-group> (<year>2001</year>). <article-title>CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses.</article-title>
<source><italic>J. Immunol.</italic></source>
<volume>166</volume>
<fpage>4634</fpage>&#x02013;<lpage>4643</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.166.7.4634</pub-id>
<pub-id pub-id-type="pmid">11254722</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C. J.</given-names></name><name><surname>Romero</surname><given-names>R.</given-names></name><name><surname>Chaemsaithong</surname><given-names>P.</given-names></name><name><surname>Chaiyasit</surname><given-names>N.</given-names></name><name><surname>Yoon</surname><given-names>B. H.</given-names></name><name><surname>Kim</surname><given-names>Y. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance.</article-title>
<source><italic>Am. J. Obstetr. Gynecol.</italic></source>
<volume>213</volume>
<fpage>S29</fpage>&#x02013;<lpage>S52</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2015.08.040</pub-id>
<pub-id pub-id-type="pmid">26428501</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kochanek</surname><given-names>K. D.</given-names></name><name><surname>Kirmeyer</surname><given-names>S. E.</given-names></name><name><surname>Martin</surname><given-names>J. A.</given-names></name><name><surname>Strobino</surname><given-names>D. M.</given-names></name><name><surname>Guyer</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>Annual summary of vital statistics: 2009.</article-title>
<source><italic>Pediatrics</italic></source>
<volume>129</volume>
<fpage>338</fpage>&#x02013;<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2011-3435</pub-id>
<pub-id pub-id-type="pmid">22291121</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>J. S.</given-names></name><name><surname>Park</surname><given-names>J. W.</given-names></name><name><surname>Park</surname><given-names>C. W.</given-names></name><name><surname>Park</surname><given-names>J. S.</given-names></name><name><surname>Jun</surname><given-names>J. K.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Chronic chorioamnionitis is the most common placental lesion in late preterm birth.</article-title>
<source><italic>Placenta</italic></source>
<volume>34</volume>
<fpage>681</fpage>&#x02013;<lpage>689</lpage>. <pub-id pub-id-type="doi">10.1016/j.placenta.2013.04.014</pub-id>
<pub-id pub-id-type="pmid">23684379</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S. M.</given-names></name><name><surname>Park</surname><given-names>J. W.</given-names></name><name><surname>Kim</surname><given-names>B. J.</given-names></name><name><surname>Park</surname><given-names>C. W.</given-names></name><name><surname>Park</surname><given-names>J. S.</given-names></name><name><surname>Jun</surname><given-names>J. K.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Acute histologic chorioamnionitis is a risk factor for adverse neonatal outcome in late preterm birth after preterm premature rupture of membranes.</article-title>
<source><italic>PloS One</italic></source>
<volume>8</volume>:<issue>e79941</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0079941</pub-id>
<pub-id pub-id-type="pmid">24324586</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindner</surname><given-names>M.</given-names></name><name><surname>Trebst</surname><given-names>C.</given-names></name><name><surname>Heine</surname><given-names>S.</given-names></name><name><surname>Skripuletz</surname><given-names>T.</given-names></name><name><surname>Koutsoudaki</surname><given-names>P. N.</given-names></name><name><surname>Stangel</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone-induced demyelination.</article-title>
<source><italic>Glia</italic></source>
<volume>56</volume>
<fpage>1104</fpage>&#x02013;<lpage>1113</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20682</pub-id>
<pub-id pub-id-type="pmid">18442092</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Xue</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Paeoniflorin attenuates Abeta1-42-induced inflammation and chemotaxis of microglia in vitro and inhibits NF-kappaB- and VEGF/Flt-1 signaling pathways.</article-title>
<source><italic>Brain Res.</italic></source>
<volume>1618</volume>
<fpage>149</fpage>&#x02013;<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2015.05.035</pub-id>
<pub-id pub-id-type="pmid">26049130</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Darnall</surname><given-names>L.</given-names></name><name><surname>Hu</surname><given-names>T.</given-names></name><name><surname>Choi</surname><given-names>K.</given-names></name><name><surname>Lane</surname><given-names>T. E.</given-names></name><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.</article-title>
<source><italic>J. Neurosci.</italic></source>
<volume>30</volume>
<fpage>9074</fpage>&#x02013;<lpage>9083</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1238-10.2010</pub-id>
<pub-id pub-id-type="pmid">20610741</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lockwood</surname><given-names>C. J.</given-names></name><name><surname>Arcuri</surname><given-names>F.</given-names></name><name><surname>Toti</surname><given-names>P.</given-names></name><name><surname>Felice</surname><given-names>C. D.</given-names></name><name><surname>Krikun</surname><given-names>G.</given-names></name><name><surname>Guller</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Tumor necrosis factor-alpha and interleukin-1beta regulate interleukin-8 expression in third trimester decidual cells: implications for the genesis of chorioamnionitis.</article-title>
<source><italic>Am. J. Pathol.</italic></source>
<volume>169</volume>
<fpage>1294</fpage>&#x02013;<lpage>1302</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2006.060185</pub-id>
<pub-id pub-id-type="pmid">17003486</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luster</surname><given-names>A. D.</given-names></name></person-group> (<year>1998</year>). <article-title>Chemokines&#x02013;chemotactic cytokines that mediate inflammation.</article-title>
<source><italic>N. Engl. J. Med.</italic></source>
<volume>338</volume>
<fpage>436</fpage>&#x02013;<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM199802123380706</pub-id>
<pub-id pub-id-type="pmid">9459648</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manjavachi</surname><given-names>M. N.</given-names></name><name><surname>Costa</surname><given-names>R.</given-names></name><name><surname>Quintao</surname><given-names>N. L.</given-names></name><name><surname>Calixto</surname><given-names>J. B.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of keratinocyte-derived chemokine (KC) on hyperalgesia caused by peripheral nerve injury in mice.</article-title>
<source><italic>Neuropharmacology</italic></source>
<volume>79</volume>
<fpage>17</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.10.026</pub-id>
<pub-id pub-id-type="pmid">24184386</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maxwell</surname><given-names>J. R.</given-names></name><name><surname>Denson</surname><given-names>J. L.</given-names></name><name><surname>Joste</surname><given-names>N. E.</given-names></name><name><surname>Robinson</surname><given-names>S.</given-names></name><name><surname>Jantzie</surname><given-names>L. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Combined in utero hypoxia-ischemia and lipopolysaccharide administration in rats induces chorioamnionitis and a fetal inflammatory response syndrome.</article-title>
<source><italic>Placenta</italic></source>
<volume>36</volume>
<fpage>1378</fpage>&#x02013;<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.1016/j.placenta.2015.10.009</pub-id>
<pub-id pub-id-type="pmid">26601766</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizugishi</surname><given-names>K.</given-names></name><name><surname>Inoue</surname><given-names>T.</given-names></name><name><surname>Hatayama</surname><given-names>H.</given-names></name><name><surname>Bielawski</surname><given-names>J.</given-names></name><name><surname>Pierce</surname><given-names>J. S.</given-names></name><name><surname>Sato</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Sphingolipid pathway regulates innate immune responses at the fetomaternal interface during pregnancy.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>290</volume>
<fpage>2053</fpage>&#x02013;<lpage>2068</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.628867</pub-id>
<pub-id pub-id-type="pmid">25505239</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morganti</surname><given-names>J. M.</given-names></name><name><surname>Jopson</surname><given-names>T. D.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Riparip</surname><given-names>L. K.</given-names></name><name><surname>Guandique</surname><given-names>C. K.</given-names></name><name><surname>Gupta</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>CCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injury.</article-title>
<source><italic>J. Neurosci.</italic></source>
<volume>35</volume>
<fpage>748</fpage>&#x02013;<lpage>760</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2405-14.2015</pub-id>
<pub-id pub-id-type="pmid">25589768</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouton</surname><given-names>P. R.</given-names></name><name><surname>Long</surname><given-names>J. M.</given-names></name><name><surname>Lei</surname><given-names>D. L.</given-names></name><name><surname>Howard</surname><given-names>V.</given-names></name><name><surname>Jucker</surname><given-names>M.</given-names></name><name><surname>Calhoun</surname><given-names>M. E.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Age and gender effects on microglia and astrocyte numbers in brains of mice.</article-title>
<source><italic>Brain Res.</italic></source>
<volume>956</volume>
<fpage>30</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(02)03475-3</pub-id>
<pub-id pub-id-type="pmid">12426043</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>P. M.</given-names></name></person-group> (<year>1997</year>). <article-title>Neutrophil receptors for interleukin-8 and related CXC chemokines.</article-title>
<source><italic>Semin. Hematol.</italic></source>
<volume>34</volume>
<fpage>311</fpage>&#x02013;<lpage>318</lpage>.<pub-id pub-id-type="pmid">9347581</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raivich</surname><given-names>G.</given-names></name><name><surname>Bohatschek</surname><given-names>M.</given-names></name><name><surname>Kloss</surname><given-names>C. U.</given-names></name><name><surname>Werner</surname><given-names>A.</given-names></name><name><surname>Jones</surname><given-names>L. L.</given-names></name><name><surname>Kreutzberg</surname><given-names>G. W.</given-names></name></person-group> (<year>1999</year>). <article-title>Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function.</article-title>
<source><italic>Brain Res. Brain Res. Rev.</italic></source>
<volume>30</volume>
<fpage>77</fpage>&#x02013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-0173(99)00007-7</pub-id>
<pub-id pub-id-type="pmid">10407127</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reaux-Le Goazigo</surname><given-names>A.</given-names></name><name><surname>Van Steenwinckel</surname><given-names>J.</given-names></name><name><surname>Rostene</surname><given-names>W.</given-names></name><name><surname>Melik Parsadaniantz</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Current status of chemokines in the adult CNS.</article-title>
<source><italic>Prog. Neurobiol.</italic></source>
<volume>104</volume>
<fpage>67</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2013.02.001</pub-id>
<pub-id pub-id-type="pmid">23454481</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redline</surname><given-names>R. W.</given-names></name></person-group> (<year>2009</year>). <article-title>Disorders of placental circulation and the fetal brain.</article-title>
<source><italic>Clin. Perinatol.</italic></source>
<volume>36</volume>
<fpage>549</fpage>&#x02013;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1016/j.clp.2009.06.003</pub-id>
<pub-id pub-id-type="pmid">19732613</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redline</surname><given-names>R. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Correlation of placental pathology with perinatal brain injury.</article-title>
<source><italic>Surg. Pathol. Clin.</italic></source>
<volume>6</volume>
<fpage>153</fpage>&#x02013;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1016/j.path.2012.11.005</pub-id>
<pub-id pub-id-type="pmid">26838708</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>S.</given-names></name><name><surname>Berglass</surname><given-names>J. B.</given-names></name><name><surname>Denson</surname><given-names>J. L.</given-names></name><name><surname>Berkner</surname><given-names>J.</given-names></name><name><surname>Anstine</surname><given-names>C. V.</given-names></name><name><surname>Winer</surname><given-names>J. L.</given-names></name><etal/></person-group> (<year>2017a</year>). <article-title>Microstructural and microglial changes after repetitive mild traumatic brain injury in mice.</article-title>
<source><italic>J. Neurosci. Res.</italic></source>
<volume>95</volume>
<fpage>1025</fpage>&#x02013;<lpage>1035</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.23848</pub-id>
<pub-id pub-id-type="pmid">27452502</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>S.</given-names></name><name><surname>Corbett</surname><given-names>C. J.</given-names></name><name><surname>Winer</surname><given-names>J. L.</given-names></name><name><surname>Chan</surname><given-names>L. A. S.</given-names></name><name><surname>Maxwell</surname><given-names>J. R.</given-names></name><name><surname>Anstine</surname><given-names>C. V.</given-names></name><etal/></person-group> (<year>2017b</year>). <article-title>Neonatal erythropoietin mitigates impaired gait, social interaction and diffusion tensor imaging abnormalities in a rat model of prenatal brain injury.</article-title>
<source><italic>Exp. Neurol.</italic></source>
<volume>302</volume>
<fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2017.12.010</pub-id>
<pub-id pub-id-type="pmid">29288070</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>S.</given-names></name><name><surname>Franic</surname><given-names>L. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Chemokine GRO1 and the spatial and temporal regulation of oligodendrocyte precursor proliferation.</article-title>
<source><italic>Dev. Neurosci.</italic></source>
<volume>23</volume>
<fpage>338</fpage>&#x02013;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1159/000048717</pub-id>
<pub-id pub-id-type="pmid">11756749</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>S.</given-names></name><name><surname>Tani</surname><given-names>M.</given-names></name><name><surname>Strieter</surname><given-names>R. M.</given-names></name><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name><name><surname>Miller</surname><given-names>R. H.</given-names></name></person-group> (<year>1998</year>). <article-title>The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation.</article-title>
<source><italic>J. Neurosci.</italic></source>
<volume>18</volume>
<fpage>10457</fpage>&#x02013;<lpage>10463</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-24-10457.1998</pub-id>
<pub-id pub-id-type="pmid">9852583</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>S.</given-names></name><name><surname>Winer</surname><given-names>J. L.</given-names></name><name><surname>Berkner</surname><given-names>J.</given-names></name><name><surname>Chan</surname><given-names>L. A.</given-names></name><name><surname>Denson</surname><given-names>J. L.</given-names></name><name><surname>Maxwell</surname><given-names>J. R.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.</article-title>
<source><italic>J. Neurosurg. Pediatr.</italic></source>
<volume>17</volume>
<fpage>739</fpage>&#x02013;<lpage>755</lpage>. <pub-id pub-id-type="doi">10.3171/2015.10.PEDS15554</pub-id>
<pub-id pub-id-type="pmid">26894518</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>S.</given-names></name><name><surname>Winer</surname><given-names>J. L.</given-names></name><name><surname>Chan</surname><given-names>L. A. S.</given-names></name><name><surname>Oppong</surname><given-names>A. Y.</given-names></name><name><surname>Yellowhair</surname><given-names>T. R.</given-names></name><name><surname>Maxwell</surname><given-names>J. R.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Extended erythropoietin treatment prevents chronic executive functional and microstructural deficits following early severe traumatic brain injury in rats.</article-title>
<source><italic>Front. Neurol.</italic></source>
<volume>9</volume>:<issue>451</issue>. <pub-id pub-id-type="doi">10.3389/fneur.2018.00451</pub-id>
<pub-id pub-id-type="pmid">29971038</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>M.</given-names></name><name><surname>Richard</surname><given-names>J. F.</given-names></name><name><surname>Dumas</surname><given-names>A.</given-names></name><name><surname>Vallieres</surname><given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>CXCL1 can be regulated by IL-6 and promotes granulocyte adhesion to brain capillaries during bacterial toxin exposure and encephalomyelitis.</article-title>
<source><italic>J. Neuroinflamm.</italic></source>
<volume>9</volume>:<issue>18</issue>. <pub-id pub-id-type="doi">10.1186/1742-2094-9-18</pub-id>
<pub-id pub-id-type="pmid">22269426</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>J. K.</given-names></name><name><surname>Cho</surname><given-names>T.</given-names></name><name><surname>Choi</surname><given-names>H. B.</given-names></name><name><surname>Jantaratnotai</surname><given-names>N.</given-names></name><name><surname>McLarnon</surname><given-names>J. G.</given-names></name></person-group> (<year>2015</year>). <article-title>Pharmacological antagonism of interleukin-8 receptor CXCR2 inhibits inflammatory reactivity and is neuroprotective in an animal model of Alzheimer&#x02019;s disease.</article-title>
<source><italic>J. Neuroinflamm.</italic></source>
<volume>12</volume>:<issue>144</issue>. <pub-id pub-id-type="doi">10.1186/s12974-015-0339-z</pub-id>
<pub-id pub-id-type="pmid">26255110</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>V.</given-names></name><name><surname>Arora</surname><given-names>S.</given-names></name><name><surname>Yadav</surname><given-names>A.</given-names></name><name><surname>Bhattacharjee</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Cytokines in recurrent pregnancy loss.</article-title>
<source><italic>Clin. Chim. Acta</italic></source>
<volume>412</volume>
<fpage>702</fpage>&#x02013;<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2011.01.002</pub-id>
<pub-id pub-id-type="pmid">21236247</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schober</surname><given-names>M. E.</given-names></name><name><surname>Requena</surname><given-names>D. F.</given-names></name><name><surname>Davis</surname><given-names>L. J.</given-names></name><name><surname>Metzger</surname><given-names>R. R.</given-names></name><name><surname>Bennett</surname><given-names>K. S.</given-names></name><name><surname>Morita</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Alpha II Spectrin breakdown products in immature sprague dawley rat hippocampus and cortex after traumatic brain injury.</article-title>
<source><italic>Brain Res.</italic></source>
<volume>1574</volume>
<fpage>105</fpage>&#x02013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2014.05.046</pub-id>
<pub-id pub-id-type="pmid">24929209</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semple</surname><given-names>B. D.</given-names></name><name><surname>Blomgren</surname><given-names>K.</given-names></name><name><surname>Gimlin</surname><given-names>K.</given-names></name><name><surname>Ferriero</surname><given-names>D. M.</given-names></name><name><surname>Noble-Haeusslein</surname><given-names>L. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species.</article-title>
<source><italic>Prog. Neurobiol.</italic></source>
<volume>106-107</volume>
<fpage>1</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2013.04.001</pub-id>
<pub-id pub-id-type="pmid">23583307</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semple</surname><given-names>B. D.</given-names></name><name><surname>Bye</surname><given-names>N.</given-names></name><name><surname>Ziebell</surname><given-names>J. M.</given-names></name><name><surname>Morganti-Kossmann</surname><given-names>M. C.</given-names></name></person-group> (<year>2010a</year>). <article-title>Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury.</article-title>
<source><italic>Neurobiol. Dis.</italic></source>
<volume>40</volume>
<fpage>394</fpage>&#x02013;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2010.06.015</pub-id>
<pub-id pub-id-type="pmid">20621186</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semple</surname><given-names>B. D.</given-names></name><name><surname>Kossmann</surname><given-names>T.</given-names></name><name><surname>Morganti-Kossmann</surname><given-names>M. C.</given-names></name></person-group> (<year>2010b</year>). <article-title>Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.</article-title>
<source><italic>J. Cereb. Blood Flow Metab.</italic></source>
<volume>30</volume>
<fpage>459</fpage>&#x02013;<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2009.240</pub-id>
<pub-id pub-id-type="pmid">19904283</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theodoric</surname><given-names>N.</given-names></name><name><surname>Bechberger</surname><given-names>J. F.</given-names></name><name><surname>Naus</surname><given-names>C. C.</given-names></name><name><surname>Sin</surname><given-names>W. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Role of gap junction protein connexin43 in astrogliosis induced by brain injury.</article-title>
<source><italic>PloS One</italic></source>
<volume>7</volume>:<issue>e47311</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0047311</pub-id>
<pub-id pub-id-type="pmid">23110066</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>H. H.</given-names></name><name><surname>Frost</surname><given-names>E.</given-names></name><name><surname>To</surname><given-names>V.</given-names></name><name><surname>Robinson</surname><given-names>S.</given-names></name><name><surname>Ffrench-Constant</surname><given-names>C.</given-names></name><name><surname>Geertman</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration.</article-title>
<source><italic>Cell</italic></source>
<volume>110</volume>
<fpage>373</fpage>&#x02013;<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(02)00838-3</pub-id>
<pub-id pub-id-type="pmid">12176324</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valles</surname><given-names>A.</given-names></name><name><surname>Grijpink-Ongering</surname><given-names>L.</given-names></name><name><surname>de Bree</surname><given-names>F. M.</given-names></name><name><surname>Tuinstra</surname><given-names>T.</given-names></name><name><surname>Ronken</surname><given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>Differential regulation of the CXCR2 chemokine network in rat brain trauma: implications for neuroimmune interactions and neuronal survival.</article-title>
<source><italic>Neurobiol. Dis.</italic></source>
<volume>22</volume>
<fpage>312</fpage>&#x02013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2005.11.015</pub-id>
<pub-id pub-id-type="pmid">16472549</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veenstra</surname><given-names>M.</given-names></name><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?</article-title>
<source><italic>J. Neuroimmunol.</italic></source>
<volume>246</volume>
<fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2012.02.016</pub-id>
<pub-id pub-id-type="pmid">22445294</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L. Y.</given-names></name><name><surname>Tu</surname><given-names>Y. F.</given-names></name><name><surname>Lin</surname><given-names>Y. C.</given-names></name><name><surname>Huang</surname><given-names>C. C.</given-names></name></person-group> (<year>2016</year>). <article-title>CXCL5 signaling is a shared pathway of neuroinflammation and blood-brain barrier injury contributing to white matter injury in the immature brain.</article-title>
<source><italic>J. Neuroinflamm.</italic></source>
<volume>13</volume>:<issue>6</issue>. <pub-id pub-id-type="doi">10.1186/s12974-015-0474-476</pub-id>
<pub-id pub-id-type="pmid">26738635</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weitkamp</surname><given-names>J. H.</given-names></name><name><surname>Guthrie</surname><given-names>S. O.</given-names></name><name><surname>Wong</surname><given-names>H. R.</given-names></name><name><surname>Moldawer</surname><given-names>L. L.</given-names></name><name><surname>Baker</surname><given-names>H. V.</given-names></name><name><surname>Wynn</surname><given-names>J. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Histological chorioamnionitis shapes the neonatal transcriptomic immune response.</article-title>
<source><italic>Early Hum. Dev.</italic></source>
<volume>98</volume>
<fpage>1</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.earlhumdev.2016.06.001</pub-id>
<pub-id pub-id-type="pmid">27318328</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Jiao</surname><given-names>T.</given-names></name><name><surname>Shi</surname><given-names>D.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>CXCR2 is essential for cerebral endothelial activation and leukocyte recruitment during neuroinflammation.</article-title>
<source><italic>J. Neuroinflamm.</italic></source>
<volume>12</volume>:<issue>98</issue>. <pub-id pub-id-type="doi">10.1186/s12974-015-0316-16</pub-id>
<pub-id pub-id-type="pmid">25990934</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>T.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Ou</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>The effect of CXCR2 inhibition on seizure activity in the pilocarpine epilepsy mouse model.</article-title>
<source><italic>Brain Res. Bull.</italic></source>
<volume>134</volume>
<fpage>91</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2017.07.003</pub-id>
<pub-id pub-id-type="pmid">28705496</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L. H.</given-names></name><name><surname>Xu</surname><given-names>G. M.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Up-regulation of CXCL1 and CXCR2 contributes to remifentanil-induced hypernociception via modulating spinal NMDA receptor expression and phosphorylation in rats.</article-title>
<source><italic>Neurosci. Lett.</italic></source>
<volume>626</volume>
<fpage>135</fpage>&#x02013;<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2015.12.044</pub-id>
<pub-id pub-id-type="pmid">26724371</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanowitz</surname><given-names>T. D.</given-names></name><name><surname>Jordan</surname><given-names>J. A.</given-names></name><name><surname>Gilmour</surname><given-names>C. H.</given-names></name><name><surname>Towbin</surname><given-names>R.</given-names></name><name><surname>Bowen</surname><given-names>A.</given-names></name><name><surname>Roberts</surname><given-names>J. M.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Hemodynamic disturbances in premature infants born after chorioamnionitis: association with cord blood cytokine concentrations.</article-title>
<source><italic>Pediatr. Res.</italic></source>
<volume>51</volume>
<fpage>310</fpage>&#x02013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1203/00006450-200203000-200203008</pub-id>
<pub-id pub-id-type="pmid">11861935</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yellowhair</surname><given-names>T. R.</given-names></name><name><surname>Noor</surname><given-names>S.</given-names></name><name><surname>Maxwell</surname><given-names>J. R.</given-names></name><name><surname>Anstine</surname><given-names>C. V.</given-names></name><name><surname>Oppong</surname><given-names>A. Y.</given-names></name><name><surname>Robinson</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Preclinical chorioamnionitis dysregulates CXCL1/CXCR2 signaling throughout the placental-fetal-brain axis.</article-title>
<source><italic>Exp. Neurol.</italic></source>
<volume>301</volume>
<fpage>110</fpage>&#x02013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2017.11.002</pub-id>
<pub-id pub-id-type="pmid">29117499</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>X.</given-names></name><name><surname>Feng</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>D.</given-names></name><name><surname>Yin</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Hou</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Roles of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible regulatory mechanisms of salvianolic acid B and carbenoxolone.</article-title>
<source><italic>J. Neuroinflamm.</italic></source>
<volume>15</volume>:<issue>97</issue>. <pub-id pub-id-type="doi">10.1186/s12974-018-1127-1123</pub-id>
<pub-id pub-id-type="pmid">29587860</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z. J.</given-names></name><name><surname>Cao</surname><given-names>D. L.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Ji</surname><given-names>R. R.</given-names></name><name><surname>Gao</surname><given-names>Y. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons.</article-title>
<source><italic>Pain</italic></source>
<volume>154</volume>
<fpage>2185</fpage>&#x02013;<lpage>2197</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2013.07.002</pub-id>
<pub-id pub-id-type="pmid">23831863</pub-id></mixed-citation></ref></ref-list></back></article>